Final Program ready for

Transcription

Table of Contents
Scientific Organizers and Scientific Advisory Board ........................................... 5
Welcoming Addresses ........................................................................................ 6
Program at a Glance ........................................................................................... 8
Oral Presentations
Tuesday, April 26 ..................................................................................... 10
Wednesday, April 27................................................................................ 11
Thursday, April 28................................................................................... 18
Friday, April 29 ........................................................................................ 25
Biosecurity Lounge ........................................................................................... 28
Poster Presentations......................................................................................... 30
General Information .......................................................................................... 58
3
4
Medical Biodefense Conference 2016
Scientific Organizers and Scientific Advisory Board
Conference Chair
Professor Dr. Lothar Zöller, Colonel (MC)
Director
Bundeswehr Institute of Microbiology
Neuherbergstrasse 11, 80937 Munich, Germany
e-mail: [email protected]
Phone: +49-(0)89-992692-3980
Conference Secretary
PD Dr. Gregor Grass
Neuherbergstrasse 11, 80937 Munich, Germany
Phone: +49-(0)89-992692-2806
Scientific Advisory Board
♦ Professor Dr. Sergei Bankoul (CHE)
Medical NBC (CBRN) Defense of the Swiss Armed Forces
♦ Professor Dr. Martin Beer (DEU)
Friedrich-Loeffler-Institute
♦ Professor Dr. Dr. Andreas Hensel (DEU)
♦
♦
♦
♦
♦
♦
♦
Federal Institute for Risk Assessment
Professor Dr. Detlev H. Krüger (DEU)
Charité Institute of Virology
Dr. Robert Massung (USA)
Centers for Disease Control and Prevention
Dr. Bärbel Niederwöhrmeier (DEU)
Bundeswehr Research Institute for Protective Technologies and CBRN Protection
Professor Dr. Georg Peters (DEU)
Münster University Institute of Microbiology
Professor Dr. Lars Schaade (DEU)
Robert-Koch-Institute
Professor Dr. Gerd Sutter (DEU)
Ludwig-Maximilians-University Munich
Dr. Gilles Vergnaud (FRA)
ENSTA ParisTech Université Paris-Saclay
5
Welcoming Addresses
Dear Colleagues,
On behalf of the Bundeswehr Institute of Microbiology,
I cordially welcome you to the 15th Medical Biodefense
Conference. This year we have decided to move the
meeting from its traditional place in October to April
and we hope very much that you will like Munich not
only at Oktoberfest time but in early spring as well.
Although challenges related to a legacy of Asbestospollution in some of our buildings have made the available space at our Bundeswehr Medical Academy even
tighter, we were still able to adhere to this venue in
order to keep the conference fee at a reasonable level.
This time we received 287 contributions for oral or
poster sessions, which is a new record, and I hope
that the scientific program compiled under the auspices of our Scientific Advisory Committee will meet your expectations. Most of the sessions will
feature at least one keynote lecture on a topic of special interest. We have once again scheduled
many parallel sessions with a lot of speedy 15-minute presentations. Nevertheless, a number of
submissions had to be converted from oral to poster presentations. We apologize for not being
able to accommodate all your preferences, but I can say we did our best. As usual, we will be
happy to honor three posters with poster awards. We thank the German Society for Military Medicine and Pharmacy and Altona Diagnostics for making this possible.
The Medical Biodefense Conference 2016 scientific program addresses the whole bandwidth of
medical biodefense topics, from political to scientific, from theoretical to practical, from mass casualties to casuistics. With regard to the recent Ebola outbreak in West Africa, time has come to
assess the lessons learned and to improve our preparedness for future outbreaks. Consequently,
the Ebola topic will be addressed in the Opening Session, but also by many other presenters
throughout the program. During the conference, you will also have an opportunity to learn more
about the recent developments in the Zika virus epidemic in the Americas, and get updates on
MERS, plague, anthrax, tick-borne encephalitis and many more topics. I also highly recommend
the Interactive Case Report Workshop to all physicians and medical students amongst us. Let me
finally draw your attention to a session featuring the activities of the German Partnership Program
for Excellence in Biological and Health Security as well as invite you to our Biosecurity Lounge,
where you can personally meet the project partners.
Finally, don´t miss to enjoy Munich in springtime. It is beautiful! For the Oktoberfest enthusiasts
among you, I should not fail to mention that Munich is celebrating its 52nd Frühlingsfest (Spring
festival, April 15 - May 1) this year on the famous Theresienwiese, the home of the Oktoberfest.
The Frühlingsfest is very much like the Oktoberfest, but on a smaller, less crazy scale.
Anyway, I hope that you will enjoy your stay in Munich and wish you an informative and pleasant
time at the Medical Biodefense Conference 2016.
Sincerely,
Prof. Dr. L. Zöller, Colonel (MC)
Conference Chair
6
Dear Conference Participants,
Fellow Soldiers,
Colleagues,
Ladies and Gentlemen,
I warmly welcome you to the 15th Medical Biodefense
Conference organized by the Bundeswehr Institute of
Microbiology in cooperation with the German Society
for Military Medicine and Pharmacy here in Munich.
Particularly with an eye on the current developments
worldwide, goals like "networking", "sharing experience" and "multinational cooperation" are no longer
just "en vogue" but actually - as we all know – are
without any alternative for operations to be successful.
Summarizing boldly and simply the mission of medical
services in general, we can say: The focus of our activities is on the health of our patients - in each and every
respect!
The efficiency of any healthcare system, among other things, depends on the expertise of a wide
array of highly qualified specialists who, by cooperating professionally, achieve the best possible
outcome and benefit.
As multifaceted as our capabilities, as different, yet, are the often unpredictable challenges we
are facing nowadays. Think, for instance, of the Ebola hemorrhagic fever virus outbreak in Africa
or most recently the fast spread of Zika virus, which caused the World Health Organization to
declare a global health emergency.
The challenges will not diminish. We, therefore, will all the more have to join forces and bethink
ourselves of the synergies inherent in the different specialties, medical licenses, and professions
in the health care system, so that we can continue promoting these invaluable resources and to
always act to the benefit of our service members but also of the society as a whole.
On that note, I wish you all an insightful conference with many interesting talks and constructive
discussions.
Dr. Tempel
Lieutenant General (MC)
Surgeon General of the Bundeswehr
7
Program at a Glance
Tuesday, April 26
Time
16:00
|
18:00
Audimax
A
18:00
|
21:30
Garden Hall
Foyer 1
Foyer 2
Biological
Threats
in the 21st Century
Welcoming Reception of the
German Society für Military Medicine and Pharmacy
at the Reception Hall
Wednesday, April 27
Time
08:30
|
10:45
11:15
|
12:30
13:30
|
15:30
16:00
|
18:00
19:00
|
22:30
8
Audimax
B
C
E
G
Garden Hall
Foyer 1
Foyer 2
What should we
learn from the
Ebola crisis?
Coffee Break
Ebola
Outbreak
Response
D
F
H
Biological
Protection and
Environmental
Hazards
Lunch Break
Emerging Zoonotic
Infections
Industrial
Exhibition
Next
Generation
Sequencing
Approaches
Poster
Exhibition
Coffee Break
Strategies for
Preparedness and
Management
Interactive
Voting Session Case Reports
Conference Dinner of the
German Society für Military Medicine and Pharmacy
at Eventstadel, Moosach (Wasserburg)
Thursday, April 28
Time
08:30
|
10:30
11:00
|
12:30
Audimax
I
K
Garden Hall
J
L
Outbreak
Management:
“Ready or Not Here I Come“
Foyer 2
Diagnostics “Sherlock“
at his best
Coffee Break
Microbial
Population
Genomics
Foyer 1
Virulence Factors
and Pathogenic
Mechanisms
Poster
Exhibition
Lunch Break
Poster Session
13:30
|
15:30
Poster
Session
Industrial
Exhibition
Coffee Break
16:00
|
16:15
16:15
|
18:15
Poster Award
Ceremony
M
Anti-Infective
Strategies Vaccines and
Antibiotics
Poster
Exhibition
N
Fostering Biosafety
for a Safer World
Friday, April 29
Time
08:30
|
10:30
Audimax
O
P
Garden Hall
Foyer 1
Foyer 2
Emerging
Diversity of
Intracellular
Agents
Coffee Break
11:00
|
13:00
Tick-Borne
Pathogens in
Nature
9
Tuesday
Audimax, 16:00 — 18:00
A
16:00
AO 01
10
Biological Threats in the 21st Century
Chairs: D. Frangoulidis (DEU) and S. Bankoul (CHE)
Biological Threats in the 21st Century: The Politics, People, Science &
Historical Roots
F Lentzos
King’s College, London, GBR
Wednesday
Audimax, 08:30 — 10:45
B
What should we learn from the Ebola crisis?
Opening Session
Chairs: L. Zöller (DEU) and G. Peters (DEU)
08:30
Opening and Welcome Notes
Conference Chair
Director Military Medical Science and Development and Deputy Commandant,
Bundeswehr Medical Service Academy
President of the German Society for Military Medicine and Pharmacy
09:00
BO 01
The Ebola outbreak in West Africa 2014-2016: operational challenges and
lessons learned.
P Formenty
World Health Organization, Geneve, CHE
09:35
BO 02
The UK Response to Ebola in Sierra Leone
AD Green
Royal Centre for Defence Medicine ,Birmingham ,GBR
10:10
BO 03
The Ebola Mission –View of the CDC
I Damon
Centers for Disease Control, Division of High-Consequence Pathogens and
Pathology, Atlanta, USA
10:45
Coffee Break
Audimax, 11:15 — 12:30
C
Ebola Outbreak Response
Chairs: R. Wölfel (DEU) and M. Carroll (GBR)
11:15
CO 01
Mobile Laboratories - Lessons-learned during the Ebola Outbreak
K Stoecker1, M Gabriel2, E Fleischmann1, A DiCaro3, G Ippolito3, S Günther2, and R
Wölfel4
1- Bundeswehr Institute of Microbiology, Med. Bio Reconnaissance& Verification,
Munich, DEU; 2- Bernhard-Nocht-Institute, Hamburg, DEU; 3- Instituto Nazionale
per le Malattie Infettive, Rome, ITA; 4- Bundeswehr Institute of Microbiology,
Bacteriology &Toxicology, Munich, DEU
11:35
CO 02
Biosafety: The Cornerstone of the French Ebola Crisis Response
L Koch1, F Janvier2, H Dampierre3, S Madec4, C Bay5, S Larreche6, F Thibault3, E
Valade1, and A Merens6
1- IRBA, Bretigny sur Orge, FRA; 2- HIA Saint Anne, Toulon, FRA; 3- DCSSA,
Paris, FRA; 4- Centre Medical des Armees, Villacoublay, FRA; 5- École du Val de
Grace, Paris, FRA; 6- HIA BEGIN, Saint Mande, FRA
11
Wednesday
11:50 BioMEDEVAC Experience of EVD-Patients in Italy: Lessons Learned
CO 03 R Biselli, A Autore, MM Lastilla, P Manfroni
Italian Air Force, Logistic Command, Medical Service, Rome, ITA
12:05 Impact of retrospective and real time sequencing on the West African Ebola
CO 04 virus outbreak
MW Carroll
Public Health England, Porton Down, Wiltshire, GBR
12:30
Lunch Break
Garden Hall, 11:15 — 12:30
D
Biological Protection and Environmental Hazards
Chairs: K. Aistleitner (DEU) and B. Niederwöhrmeier (DEU)
11:15 Vecoys and becoys, newly developed nanoparticles for targeted destruction of
DO 01 viral and bacterial agents
ME El Zowalaty, and TJ Webster
Northeastern University, Department of Chemical Engineering, Boston, USA
11:30 Nanosilver System Technology - Countermeasure Against Bioterrorism
DO 02 H Schmid
Fraunhofer-Institute for Chemical Technology (ICT), Nanotechnology (ES), Pfinztal,
DEU
11:45 Assessing the Economic Feasibility of Developing Medical Countermeasures
DO 03 against Rare, but Highly Dangerous Agents
ML Johnson1, F Dorandeu2, J Belin3, and M Guille4
1- MJ Lawrence Consulting, Munich, DEU; 2- Armed Forces Biomedical Research
Institute (IRBA), Brétigny-sur-Orge, FRA; 3- University Bordeaux 4, Gretha -UMR
CNRS 5113, Bordeaux, FRA; 4- Université Panthéon-Assas, LEMMA & Labex MMEDII, Paris, FRA
12:00 The wide spread distribution of Bacillus cereus biovar anthracis requires
DO 04 practical and cost-effective tool monitoring tools
C Hoffmann1, F Zimmermann2, K Nowak1, K Grützmacher1, S Dupke2, K Merkel1, H
Kühl3, R Grunow2, S Klee2, S Calvignac-Spencer1, and F Leendertz1
1- Robert Koch-Institute, Epidemiology of Highly Pathogenic Microorganisms, Berlin,
DEU; 2- Robert Koch-Institute, Centre for Biological Threats and Special Pathogens,
Berlin, DEU; 3- Max Planck Institute for Evolutionary Anthropology, Primatology,
Leipzig, DEU
12:15 Safety Cabinets - A fundamental protective device
DO 05 T Hinrichs
Berner International GmbH, Elmshorn, DEU
12:30
12
Lunch Break
Wednesday
Audimax, 13:30 — 15:30
E
Emerging Zoonotic Infections
Advanced training session by the Center for Infection Medicine Munich (CIMM)
Chairs: A. Fasanella (ITA) and J. Schmidt-Chanasit (DEU)
13:30
EO 01
Emerging viral zoonotic infections of the central nervous system
D Tappe
Bernhard Nocht Institute, Hamburg, DEU
13:50
EO 02
Zika virus emergence in the Americas – A potential threat to Europe?
J Schmidt-Chanasit
WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and
Research, Department of Arbovirology, Hamburg, DEU
14:10
EO 03
SARS vs MERS: a comparison based on clinical and epidemiological data
G Jahn
Institute of Medical Virology and Epidemiology of Viral Disease, University Hospital
of Tübingen, Tübingen, DEU
14:30
EO 04
Prevalence rates of Rift Valley Fever infections in Mauritania, Sierra Leone,
Cameroon and the Democratic Republic of Congo
M Eiden, M Rissmann, and MH Groschup
Institut für Neue und Neuartige Tierseuchenerreger, Friedrich-Loeffler-Institut,
Greifswald-Insel Riems, DEU
14:45
EO 05
Detection of human infections by non-rodent associated hantaviruses in Africa
P Heinemann1, PT Witkowski1, SS Essbauer2, N Kruger1, CG Akoua-Koffi3, F
Schaumburg4, FH Leendertz5, and DH Kruger1
1- Charité School of Medicine, Institute of Virology, Berlin, DEU; 2- Bundeswehr,
Institute of Microbiology, Munich, DEU; 3- University of Bouake, Centre de
Recherche pour le Developpement, Bouake, CIV; 4- University Hospital Munster,
Medical Microbiology, Munster, DEU; 5- Robert Koch-Institute, Berlin, DEU
15:00
EO 06
Analysis of bat-borne Makokou virus underlines the risk of emergence of nonconventional hantaviruses
PT Witkowski1, JF Drexler2, R Kallies2, M Lickova3, S Bokorova4, GD Maganga5, T
Szemes4, EM Leroy5, DH Kruger1, C Drosten2, and B Klempa1
1- Charité School of Medicine, Institute of Virology, Berlin, DEU; 2- University of
Bonn Medical Center, Institute of Virology, Bonn, DEU; 3- Slovak Academy of
Sciences, Institute of Virology, Bratislava, SVK; 4- Comenius University, Department
of Molecular Biology, Bratislava, SVK; 5- Centre International de Recherches
Médicales, Franceville, GAB
15:15
EO 07
Hantavirus in Pet Rats: A Newly Emerging Disease in the UK
J Duggan1, R Close2, L McCann3, N McCarthy4, T Mannes5, D Wright6, M Keys1, A
Walsh7, A Charlett8, and T Brooks1
1- Public Health England, Rare and Imported Pathogens Laboratory, Salisbury,
GBR; 2- Public Health England, CRCE, Oxford, GBR; 3- NHS South Gloucestershire
13
Wednesday
Trust, Gloucester, GBR; 4- Warwick University, Warwick Medical School, Warwick,
UK; 5- Public Health England, Health Protection Services, Oxford, GBR; 6- Public
Health England, Virus and Pathogenesis group, Salisbury, GBR; 7- Public Health
England, Gastrointestinal, Emerging and Zoonoses Infections, London, GBR; 8Public Health England, Statistics and Economic Modelling Department, London,
GBR
15:30
Coffee Break
Garden Hall, 13:30 — 15:30
F
14
Next Generation Sequencing Approaches
Chairs: N. Loman (GBR) and L. Baillie (GBR)
13:30
FO 01
Uniting diagnostics and pathogen surveillance with sequencing
NJ Loman
University of Birmingham, Institute for Microbiology and Infection, Birmingham, GBR
13:55
FO 02
Sequencing’s day out: Take your mini on the field
MH Antwerpen, E Georgi1, GH Genzel1, K Stoecker2, and MC Walter1
1- Bundeswehr Institute of Microbiology, Microbial Genomics and Bioforensics,
Munich, DEU; 2- Bundeswehr Institute of Microbiology, Reconnaissance and
Verification, Munich, DEU
14:15
FO 03
Genome Analysis Reveals Identical Francisella tularensis Strains Across
Large Spatial and Temporal Distances
DM Wagner1, A Johansson2, C Dwibedi2, D Birdsell1, K Myrtennäs3, J Thelaus3,
P Keim1, and M Forsman3
1- Northern Arizona University, Flagstaff, AZ, USA; 2- Umeå University, Umeå,
SWE; 3- Swedish Defense Research Agency, Umeå, SWE
14:35
FO 04
Unique genome of a European variola virus identified in a 100 year-old
preserved tissue
P Pajer1, J Dresler1, D Elleder2, H Kabickova1, L Pisa1, P Aganov1, V Kuzelka3, P
Veleminsky3, J Klimentova3, A Fucikova4, J Peichal4, V Benes5, T Raush6, P Dundr6,
A Pilin6, A Cabala6, M Hubalek7, J Stribrny8, K Fucik8, M Antwerpen9, and H Meyer9
1- Military Health Institut, Prague, CZE; 2- Institute of Molecular Genetics, Prague,
CZE; 3- National Museum, Prague, CZE; 4- Faculty of Military Health Sciences,
Hradec Kralove, CZE; 5- Genomics Core Facility, EMBL, Heidelberg, DEU; 6 Faculty of Medicine, Prague, CZE; 7 - State Office for Nuclear Safety, Prague, CZE;
8 - Military Institute of Forensic Medicine, Prague, CZE; 9 - Bundeswehr Institute of
Microbiology, Munich, DEU
14:50
FO 05
BSL3-4 agents in the Czech National Museum depository and their value for
the study of these organisms
J Dresler1, P Pajer1, D Elleder1, T Hron2, H Kabickova1, P Aganov1, L Pisa1, V
Kuzelka1, P Veleminsky3, J Klimentova3, A Fucikova4, V Benes4, T Rausch5, P
Wednesday
Dundr5, A Pilin6, R Cabala6, M Hubalek6, J Stribrny6, K Fucik1, E Liebler-Tenorio1, M
Elschner9, M Antwerpen10, and H Meyer10
1- Military Health Institute, Prague, CZE; 2- Institute of Molecular Genetics AS CR,
Prague, CZE; 3- National Museum, Prague, CZE; 4- Faculty of Military Health
Sciences, Prague, CZE; 5- Genomics Core Facility, EMBL, Heidelberg, DEU; 6- 1st
Faculty of Medicine UK, Prague, CZE; 7- Institute of Organic Chemistry and
Biochemistry AS, Prague, CZE; 8- Central Military Hospital, Prague, CZE; 9Friedrich Loeffler Institut, Jena, DEU; 10- Bundeswehr Institute of Microbiology,
Munich, DEU
15:05
FO 06
Structure of recombination sites in the genome of the european subtype
strains of tick borne encephalitis virus, revealed by bioinformatics methods
Y Dzhioev1, A Paramonov1, I Kozlova1, S Tkachev2, O Suntsova1, E Doroschenko1,
O Lisak1, T Demina3, A Lyapunov2, V Zlobin4, D Kiselev4, D Ruzek5, and D Ruzek5
1- Scientific Centre of Family Health and Human Reproduction Problems, Irkutsk,
RUS; 2- Institute of Chemical Biology and Fundamental Medicine SB RAS,
Novosibirsk, RUS; 3- Irkutsk State Academy of Agriculture, Irkutsk, RUS; 4- Irkutsk
State Medical University, Irkutsk, RUS; 5- Veterinary Research Institute, Department
of Virology, Brno, CZE
15:30
Coffee Break
Audimax, 16:00 — 18:00
G
Strategies for Preparedness and Management
Chairs: H. Meyer (DEU) and L. Schaade (DEU)
16:00 Implications of rare non-predictable unknown infectious disease threats on
GO 01 emergency and disaster management planning
NG Schwarz
Bernhard-Nocht-Institut für Tropenmedizin, Hamburg, Global Partnership Initiated
Biosecurity Academia for Controlling Health Threats (GIBACHT), Hamburg, DEU
16:15 Assessing Measures to Mitigate the Effects of an Emerging Infectious Disease
GO 02 RL Cubeta, and JK Burr
Institute for Defense Analyses, Strategy, Forces, and Resources Division,
Alexandria, Virginia, USA
16:30 NATO working group HFM RTG 230: “Development of depository of fast and
GO 03 reliable detection methods for zoonotic and vector-borne agents”
L Wilmaerts1, C Cochez1, V Neubauerova2, J Marié3, A Binder4, U Schotte4, M
Faulde5, S Essbauer6, F Lista7, G Faggioni7, D Popescu8, A Zerjav9, P WardDemo10, C Vandenvelde1, and P Heyman1
1- Military Hospital Queen Astrid, Brussels, BEL; 2- Military Health Institute, Prague,
CZE; 3- Regional Medical Command, Toulon, FRA; 4- Central Institute of the
Bundeswehr Medical Service Kiel, Department of Veterinary Medicine, Kronshagen,
DEU; 5- Central Institute of the Bundeswehr Medical Service, Laborgruppe
15
Wednesday
Medizinische Zoologie, Koblenz, DEU; 6- Institute for Microbiology of the
Bundeswehr, Munich, DEU; 7- Army Medical and Veterinary Research Center,
Rome, ITA; 8- Military Medical Research Center, Bucharest, ROU; 9- Military
Veterinary Unit, Kocevska Reka, SVN; 10- US Africa Command, Stuttgart, DEU
16:45 The Analytical Task Force Biology
GO 04 S Lenerz, N Derakshani, and M Hermann-Pietsch
Federal Office of Civil Protection and Disaster Assistance, science and technology,
Bonn, DEU
17:00 Building Capacity for Pandemic Influenza and Emerging Infectious Disease
GO 05 Preparedness in the US European Command Area of Responsibility
KC Allen, and JA Steele
U.S. European Command Headquarters, Counter Biothreats Cell, Stuttgart, DEU
17:15 Nordic biopreparedness network initiative
GO 06 M Byström1, SL Feruglio2, K Fuursted3, S Helgadóttir4, M Bronislaw Oleksiewicz3, J
Strand Olsen5, S Sissonen6, and A Lundin Zumpe7
1- Swedish Defence Research agency, Umeå, SWE; 2- Norwegian Institute of Public
Health, Oslo, NOR; 3- Statens Serum Institut, Copenhagen, DNK; 4- LandspitaliUniversity Hospital, Reykjavík, ISL; 5- Norwegian Defence Research Establishment,
Kjellner, NOR; 6- National Institute for Health and Welfare, Helsinki, FIN; 7- National
Food Agency, Uppsala, SWE
17:30 The Role of Biosafety Associations in Global Biosecurity and Rising
GO 07 Awareness on Dual-Use Issues in Biomedical Research
LG Bakanidze1, MD Natsvlishvili1, and NV Chakvetadze2
1- Georgian Biosafety Association, Tbilisi, GEO; 2- National Center for Disease
Control and Public Health, Tbilisi, GEO
17:45
GO 08
ι
18:00
16
Ten Years of Finnish Interagency Collaboration on Biothreat Preparedness –
BUOS and GHSA
S Nikkari
Centre for Military Medicine, Research and Development Department, Helsinki, FIN
Wednesday
Garden Hall, 16:00 — 17:40
H
Interactive Voting Session - Case Reports
and the German Society for Military Medicine and Pharmacy
Chairs: S. Zange (DEU) and D. Tappe (DEU)
16:00
HO 01
Emerging infectious diseases linked to the refugee crisis
LA Balzer
Munich Municipal Hospital Schwabing, Department of infectious diseases and
tropical medicine, Munich, DEU
16:20
HO 02
Acute cardiopulmonary syndrome in a 58-yr-old female patient
M Simon
University Hospital Regensburg, Institute for Medical Microbiology and Hygiene,
Regensburg, DEU
16:40
HO 03
Fever, rash, myalgia and conjunctivitis after travel to South America
D Tappe
Bernhard Nocht Institute, Hamburg, DEU
17:00
HO 04
Skin lesion of unknown origin
IB Eder
University Hospital,Leipzig , Institute of Medical Microbiology and Epidemiology of
Infectious Diseases, Leipzig, DEU
17:20
HO 05
Ι
17:40
Just a little skin blister...
T Holzmann, and U Reischl
Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg,
Regensburg, DEU
17
Thursday
Audimax, 08:30 — 10:30
I
18
Outbreak Management: “Ready or Not - Here I Come“
Chairs: T. Ingles (AUS) and G. Genzel (DEU)
08:30
IO 01
Melioidosis: a decade of international bioreconnaissance.
TJ Inglis1 and AJ Merritt2
1- University of Western Australia, School of Pathology & Laboratory Medicine, Crawley,
AUS; 2- PathWest Laboratory Medicine, Department of Microbiology, Nedlands, AUS
09:00
IO 02
Outbreak response in the aftermath of West Africa´s Ebola Crisis – VISIT: a civilmilitary interface pilot.
K Rossmann
Bundeswehr Medical Headquarters, Munich, DEU
09:15
IO 03
Pneumonic plague outbreak of Mandritsara: the involvement of traditional healers
V Andrianaivoarimanana1, R Rabeviloma2, N Randriananja3, MO Raveloson2, and M
Rajerison1
1- Institut Pasteur de Madagascar, Plague Unit, Antananarivo, MDG; 2- Ministry of
Health, District Service of Public Health, Mandritsara, MDG; 3- Ministry of Health,
Central laboratory for Plague, Antananarivo, MDG
09:30
IO 04
Generic action plan for biological danger situations
D Oberndörfer1, V Wilken1, R Gottschalk2, H Jung2, and E Finke3
1- Frankfurter Institut für Rettungsmedizin & Notfallversorgung, Branddirektion Frankfurt,
Frankfurt/Main, DEU; 2- Gesundheitsamt Frankfurt, Frankfurt/Main, DEU; 3- AKNZ,
München, DEU
09:45
IO 05
After Ebola: Moving forward on preparedness for unusual disease outbreaks
I Hunger
Robert Koch Institute, ZBS, Berlin, DEU
10:00
IO 06
Causative Food Unknown? Investigational Tracing of Foods as a Tool for
Outbreak Management
P Luber, N Becker, K Heckenbach, D Raschke, and T Schewe
Federal Office of Consumer Protection and Food Safety (BVL), Food Safety, Berlin,
DEU
10:15
IO 07
An Anthrax Outbreak in a Village in Central Anantolia and Infection Control
Studies
M Doganay1, H Demiraslan1, A Borlu2, S Sahin3, F Büyük4, Y Karadag3, and M Sahin4
1- Erciyes University, Department of Infectious Diseases, Kayseri, TUR; 2- Erciyes
University, Department of Public Health, Kayseri, TUR; 3- Ministry of Health, Public
Health Service, Kayseri, TUR; 4- Kafkas University, Department of Microbiology,
Veterinary Faculty, Kars, TUR
10:30
Coffee Break
Thursday
Garden Hall, 08:30 — 10:30
J
Diagnostics - “Sherlock“ at his best
Chairs: M. Beer (DEU) and D. Frangoulidis (DEU)
08:30
JO 01
Rapid Diagnostics and Pen-Side Testing – State-of-the-Art
S Blome, K Goller, K Wernike, B Hoffmann, and M Beer
Friedrich-Loeffler-Institut, Institute of Diagnostic Virology, Greifswald-Insel Riems, DEU
08:55
JO 02
Benefits and Limitations of Cartridge-based Tests in Molecular Diagnostics of
Infectious Diseases
U Reischl
University Hospital Regensburg, Institute of Medical Microbiology and Hygiene,
Regensburg, DEU
09:20
JO 03
FISH for diagnosis of infections: Closing the gap between bench and bedside
A Moter
Biofilmcenter, German Heart Institute Berlin, Berlin, DEU
09:45
JO 04
Development of a sensitive and specific real-time RT-PCR for simultaneous
detection of Dengue and Zika virus infections
S Wölfel1, T Löscher2, G Dobler1, and R Wölfel3
1- Bundeswehr Institute of Microbiology, Virology & Rickettsiology, Munich , DEU; 2Ludwig Maximilians University of Munich, Department of Infectious Diseases and
Tropical Medicine, Munich, DEU; 3- Bundeswehr Institute of Microbiology, Bacteriology,
Munich, DEU
10:00
JO 05
Culture-independent serotyping of Legionella pneumophila in water, aerosol and
urine samples
C Kober1, A Wunderlich1, C Herr2, C Lück3, R Niessner1, and M Seidel1
1- Technical University of Munich, Institute of Hydrochemistry, Chair of Analytical
Chemistry, Munich, DEU; 2- Occupational and Environmental Health, Epidemiology,
Bavarian Health and Food Safety Authority, Munich, DEU; 3- Technical University of
Dresden, Institute of Medical Microbiology and Hygiene, Institute of Virology, Medical
Faculty "C.G. Carus", Dresden, DEU
10:15
JO 06
Interlaboratory validation for antimicrobial susceptibility testing of highly
pathogenic bacteria – results of the QUANDHIP AST working group
S Zange, P Bolton2, T Boskani3, G Ezpeleta4, E Georgi1, R Grunow5, P Jureen3, J
Papaparaskevas6, O Telleria4, BR Thoma1, A Tsakris6, T Wahab3, and D Jacob5
1- Bundeswehr Institute of Microbiology, Central Diagnostic Unit, Munich, DEU; 2- Public
Health England, Rare and Imported Pathogens Laboratory, Porton Down, GBR; 3- Public
Health Agency of Sweden, Department of Microbiology, Stockholm, SWE; 4- Basurto
University Hospital, Clinical Microbiology and Infection Control Department, Bilbao, ESP;
5- Robert Koch-Institut, Centre for Biological Threats and Special Pathogens (ZBS 2),
Berlin, DEU; 6- National and Kapodistrian University of Athens, Medical School,
Microbiology Department, Athens, GRC
Coffee Break
10:30
19
Thursday
Audimax, 11:00 — 12:30
K
20
Microbial Population Genomics
Chairs: P. Keim (USA) and G. Vergnaud (FRA)
11:00
KO 01
Anthrax Genomics for Investigating Disease Outbreaks
P Keim
Northern Arizona University, Flagstaff, AZ, USA
11:25
KO 02
The scientific names of bacterial pathogens: the importance of trivia.
BJ Tindall
Leibniz-Institut DSMZ, Braunschweig, DEU
11:40
KO 03
Phylogenomics and geographic distribution of Bacillus cereus biovar
anthracis in sub-Saharan Africa
SR Klee1, KS Antonation2, K Grützmacher3, S Dupke1, P Mabon2, F Zimmermann1,
R Grunow1, S Calvignac-Spencer3, CR Corbett2, and FH Leendertz3
1- Robert Koch-Institut, ZBS2 (Highly Pathogenic Microorganisms), Berlin, DEU; 2Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, CAN;
3- Robert Koch-Institut, P3 (Epidemiology of Highly Pathogenic Microorganisms),
Berlin, DEU
11:55
KO 04
Updating the Brucella MLVA database
G Vergnaud1, Y Hauck1, C Pourcel1, I Jacques2, A Cloeckaert2, and M Zygmunt2
1- University Paris-Saclay, I2BC, ORSAY, FRA; 2- INRA, Infectiologie et Santé
Publique, Nouzilly, FRA
12:10
KO 06
Characterization of Clostridum botulinum group I through a 134 SNPs Panel
S Fillo1, F Giordani1, A Anselmo1, F Anniballi2, A Fortunato1, A Palozzi1, B Gentile1,
D Azarnia Tehran1, A Ciammaruconi1, F Spagnolo1, V Pittiglio1, B Auricchio2, J
Dresler3, L Píša4, J Klimentová4, D De Medici2, and F Lista1
1- Army Medical and Veterinary Research Center, Molecular Biology Section, Rome,
ITA; 2- Istituto Superiore di Sanità, Department of Veterinary Public Health and Food
Safety, National Reference Center for Botulism, Rome, ITA; 3- Military Health
Institute, Prague, CZE; 4- Faculty of Military Health Sciences, Hradec Králové, CZE
12:20
KO 07
Insights into microevolution of Burkholderia mallei gained during an
experimental infection within its natural host
E Georgi1, U Wernery2, MH Antwerpen1, R Wernery2, and HC Scholz1
1- Bundeswehr Institute of Microbiology, Munich, DEU, 2- Central Veterinary
Research Laboratory, Dubai, ARE
12:30
Lunch Break
Thursday
Garden Hall, 11:00 — 12:30
L
Virulence Factors and Pathogenic Mechanisms
Chairs: A. Charbit (FRA) and H. von Buttlar (DEU)
11:00
LO 01
Metabolism and Francisella tularensis intracellular adaptation
A Charbit
Université Paris, Institut Necker-Enfants Malades, Paris, FRA
11:20
LO 02
Q-detect: using cell mediated immunity to monitor C. burnetii infections
A Garritsen1, HI Roest2, MJ de Vries-van der Horst1, PM Schneeberger3, and ML
Kouwijzer1
1- Innatoss Laboratories, Oss, NLD; 2- Central Veterinary Institute, Lelystad,
Netherlands; 3- Jeroen Bosch Hospital, LMM, Den Bosch, NLD
11:35
LO 03
Identification of Novel Bacillus anthracis Virulence Factors by a Proteomic/
Serological Approach and their Application in Vaccine Development
T Chitlaru, M Israeli, E Barhaim, U Elia, S Rotem, S Ehrlich, O Cohen, and A
Shafferman
Israel Institute for Biological Research, Biochemistry and Molecular Genetics, Ness
Ziona, ISR
11:50
LO 04
The Impact of Environmental Contamination with Bacillus anthracis Spores on
Human Health
F Buyuk1, O Celebi1, E Linley2, C Cooper3, M Doganay4, M Sahin1, and L Baillie2
1- Kafkas University, Department of Microbiology, Kars, TUR; 2- Cardiff University,
School of Pharmacy and Pharmaceutical Science, Cardiff, GBR; 3- Stockholm
University, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm, SWE; 4- Erciyes University, Department of Infectious Diseases, Kayseri, TUR
12:05
LO 05
An in vitro evaluation of epigallocatechin gallate (eGCG) as a biocompatible
inhibitor of ricin and Clostridium difficile toxins.
P Dyer1, S Shorter1, S Richardson1, and L Baillie2
1- University of Greenwich, Life and Sport Science, Chatham Maritime, GBR; 2University of Cardiff, School of Pharmacy & Pharmaceutical Science, Cardiff, GBR
12:20
LO 06
Qualitative and quantitative detection of botulinum neurotoxins from complex
matrices: results of the first international proficiency test
S Worbs1, U Fiebig1, R Zeleny2, H Schimmel2, A Rummel3, W Luginbühl4, and BG
Dorner1
1- Robert Koch Institut, ZBS3, Berlin, DEU; 2- European Commission, Joint
Research Centre, Institute for Reference Materials and Measurements, Geel, BEL;
3- toxogen GmbH, Hannover, DEU; 4- ChemStat, Bern, CHE
12:30
Lunch Break
21
Thursday
Audimax, 16:15 — 18:10
M
Anti-Infective Strategies - Vaccines and Antibiotics
Chairs: G. Sutter (DEU) and L. Zöller (DEU)
16:15 Who needs anthrax vaccine?
MO 01 H Dyson
Dstl Porton Down, Salisbury, GBR
16:40 Ebola vaccine development – Which lessons did we learn?
MO 02 A von Krempelhuber, M Saeftel, and J Vollmar
GlaxoSmithKline GmbH & Co. KG, Medical Therapeutic Area Vaccines, Travel- and
Tropical Medicine, Munich, DEU
16:55 Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering
MO 03 Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
A Volz1, A Kupke2, F Song1, S Jany1, R Fux1, H Shams-Eldin2, J Schmidt2, C Becker3,
M Eickmann2, S Becker2, and G Sutter1
1- LMU Munich, Institute for Infectious Diseases and Zoonoses, Chair for Virology, Munich,
DEU; 2- Philipps University Marburg, Institute of Virology, Marburg, DEU; 3- University of
Giessen Lung Center, Department of Internal Medicine II, Section of Infectious Diseases,
Giessen, DEU
17:10 Update on MVA-BN® Smallpox Vaccine (IMVANEX®/IMVAMUNE®) and Use of the
MO 04 MVA-BN® Platform to address the Need for an Ebola Vaccine
N Samy1, A Volkmann2, B Petzold3, and P Chaplin4
1- Bavarian Nordic, Clinical Development, Martinsried, DEU; 2- Bavarian Nordic, Early
Development, Martinsried, DEU; 3- Bavarian Nordic, Regulatory, Martinsried, DEU; 4Bavarian Nordic, Executive Management, Kvistgard, DNK
17:25 Finafloxacin Evades Burkholderia pseudomallei Efflux-mediated Fluoroquinolone
MO 05 Resistance
LB Randall, E Georgi, GH Genzel2, and HP Schweizer1
1- University of Florida, Molecular Genetics and Microbiology, Gainesville, USA; 2Bundeswehr Institute of Microbiology, Munich, DEU
17:40 Therapeutic efficacy of single and combined antibiotic treatments against Anthrax
MO 06 S Weiss, Z Altboum, I Glinert, A Sittner, E Bar David, D Kobiler, and H Levy
IIBR, Infectious Diseases, Ness-Ziona, ISR
17:55 Q-VaxCelerate: Development of a T Cell-Based Vaccine for Q Fever
MO 07 A Garritsen1, L Moise2, PB Reeves3, G Richard2, S Raju Paul3, TA Luijjkx1, L Baeten4, RA
Bowen4, R Bucala5, A Sluder3, and MB Poznansly3
1- Innatoss Laboratories BV, Oss, NLD; 2- Epivax, Providence RI, USA; 3- Massachusetts
General Hospital, Vaccine and Immunotherapy Center, Charlestown MA, USA; 4Colorado State University, Animal Reproduction and Biotechnology Laboratory, Fort
ι
Collins CO, USA; 5- Yale School of Medicine, Department of Internal Medicine, New
18:10 Haven CT, USA
22
Thursday
Garden Hall, 16:15 — 18:40
N
Fostering Biosafety for a Safer World
Advanced training session by the German Partnership Program for Excellence
in Biological and Health Security
Chairs: R. Surkau (DEU) and S. Essbauer (DEU)
16:15 Fostering Biosafety and Biosecurity for a Safer World: The Example of the
NO 01 German Partnership Program for Excellence in Biological and Health Security
R Surkau1, W Biederbick2, and J Von Bonin3
1- German Federal Foreign Office, Program Director of the German Partnership
Program for Excellence in Biological and Health Security and Deputy Head of the
German Federal Foreign Office’s Division for Biological and Chemical Arms Control,
Disarmament and Non-Proliferation, Berlin, DEU; 2- Robert Koch Institute, Head of
the Program Office and Program Coordinator of the German Partnership Program
for Excellence in Biological and Health Security at the Robert Koch Institute and
Head of the Department ‘Strengthening Global Biosecurity’ at the Robert Koch
Institute, Berlin, DEU; 3- Deutsche Gesellschaft für Internationale Zusammenarbeit
(GIZ) GmbH, Program Manager of the German Partnership Program for Excellence
in Biological and Health Security at GIZ, Berlin, DEU
16:45 The Role of German-Sudanese Partnership in Strengthening Biorisk
NO 02 Management in the Republic of the Sudan
BI Fadul1, IE Andernach2, R Stelter3, J Wolf4, A Abdulkarim1
1- National Public Health Laboratory, Khartoum, SDN; 2- Robert Koch Institute,
Centre for Biological Threats and Special Pathogens - Highly Pathogenic
Microorganisms, Berlin, DEU; 3- Deutsche Gesellschaft für Internationale
Zusammenarbeit (GIZ) GmbH, Section Security, Crisis Management, Refugee
Programmes, Berlin, DEU; 4- Robert Koch Institute, Strengthening Global
Biosecurity, Berlin, DEU
17:00 Early Warning System in Tunisia: Evolution, Challenges and Role of
NO 03 Laboratory, Biosecurity, Environment and Modeling of Infectious Diseases
NB Ben Alaya1, S El Bekri2, M Nachtnebel3, L Hollenweger4, and D Kücükali4
1- National Observatory for New and Emerging Diseases of the Ministry of Health,
Tunis, TUN; 2- Directorate for Primary Health Care of the Ministry of Health, Tunis,
TUN; 3- Expert Surveillance Unit of the German Partnership Program for Excellence
in Biological and Health Security at Robert Koch Institute (RKI), Berlin, DEU; 4German Partnership Program for Excellence in Biological and Health Security at
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), Berlin, DEU
17:15 Thematic and operational approaches for biosafety and biosecurity in
NO 04 Morocco after the Ebola crisis
A Maaroufi1, D Röntgen2, and Lilian Hollenweger2
1- Moroccan Ministry of Health, Department of Epidemiology and Disease Control,
Rabat, MAR; 2- Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)
GmbH, German Partnership Program for Excellence in Biological and Health
Security, Berlin, DEU
23
Thursday
17:30 Mobile laboratory unit for the fight against Ebola in Mali
NO 05 B Kouriba1, B Traoré1, L Timbiné1, A Maiga1, Y Timbiné1, A Touré1, M Knuepfer2, E
Fleischmann2, S Thumann2, L Fofona3, F Xavier3, M Summerer4, J Von Bonin4, S
Diallo1, and R Woelfel2
1- Centre d’Infectiologie Charles Mérieux du Mali, Bamako, MLI; 2- Bundeswehr
Institute of Microbiology, Department of Bacteriology and Toxinology, Munich, DEU;
3- Foundation Mérieux, Bamako, MLI; 4- Gesellschaft für Internationale
Zusammenarbeit (GIZ) GmbH, Berlin, DEU
17:45 The Global Partnership Initiated Biosecurity Academia for Controlling Health
NO 06 Threats (GIBACHT)
NG Schwarz1, M Lee2, N Gilberger1, J Pelikan3, E Rutebemberwa4, and A Hoffmann3
1- Bernhard-Nocht-Institut für Tropenmedizin, Hamburg, Global Partnership Initiated
Biosecurity Academia for Controlling Health Threats (GIBACHT), Hamburg, DEU; 2Robert Koch Institute, Global Partnership Initiated Biosecurity Academia for
Controlling Health Threats (GIBACHT), Berlin, DEU; 3- Swiss Tropical and Public
Health Institute, Global Partnership Initiated Biosecurity Academia for Controlling
Health Threats (GIBACHT), Basel, CHE; 4- African Field Epidemiology Training
Network (AFENET), Global Partnership Initiated Biosecurity Academia for
Controlling Health Threats (GIBACHT), Kampala, UGA
18:00 Livestock Brucellosis in Pakistan
NO 07 H El-Adawy1, I Khan2, F Melzer1, and H Neubauer1
1- Friedrich Loeffler Institut, Institute for Bacterial Infections and Zoonoses, Jena,
DEU; 2- College of Veterinary and Animal Sciences, Section of Epidemiology and
Public Health, Jhang, PAK
18:15 The biological safety system in Kazakhstan
NO 08 A Aikimbayev
Sci Pract. Center San. Epid. Expertise and Monitoring, Almaty, KAZ
ι
18:40
24
Friday
Audimax, 08:30 — 10:30
O
Emerging Diversity of Intracellular Agents
Chairs: R. Massung (USA) and S. Wölfel (DEU)
08:30 Diagnosis and Treatment of Rickettsial Diseases: Pitfalls and Recent
OO 01 Advances
RF Massung
Centers for Disease Control and Prevention, Rickettsial Zoonoses Branch, Division
of Vector-Borne Diseases, Atlanta, GA, USA
09:00 Assessment of Coxiella burnetii strain differences in virulence and the innate
OO 02 immune response of humans
H Roest1, R Kuley2, A Ammerdorffer3, and A Bossers2
1- Central Veterinary Institute, part of Wageningen UR, Bacteriology and
Epidemiology, Lelystad, NLD; 2- Central Veterinary Institute, part of Wageningen
UR, Infection Biology, Lelystad, NLD; 3- Radboud University Medical Center, Internal
Medicine, Nijmegen, NLD
09:30 First Molecular Detection of Rickettsia massiliae in Ticks from Tanzania
OO 03 B Flach1, M Knüpfer2, K Baumann1, L Chitimia-Dobler1, NE Ntinginya3, L Maboko3, N
Heinrich4, M Hölscher4, and G Dobler1
1- Bundeswehr Institute of Microbiology, Virology and Rickettsiology, Munich, DEU;
2- Bundeswehr Institute of Microbiology, Bacteriology and Toxinology, Munich, DEU;
3- NIMR-Mbeya Medical Research Centre, Mbeya, TZA; 4- Division for Infectious
Diseases and Tropical Medicine, University of Munich, Munich, DEU
09:45 Survey for the zoonotic bacteria Leptospira and Rickettsia in wild small
OO 04 mammal populations in Germany
S Fischer1, A Mayer-Scholl2, S Essbauer3, N Kratzmann1, C Imholt4, D Reil4, S
Schmidt1, UM Rosenfeld1, J Jacob4, K Nöckler2, and RG Ulrich1
1- Friedrich-Loeffler-Institut, Institute for Novel and Emerging Infectious Diseases,
Greifswald-Insel Riems, DEU; 2- Federal Institute for Risk Assessment, Department
for Biological Safety, Berlin, DEU; 3- Bundeswehr, Institute of Microbiology, Munich,
DEU; 4- Julius Kühn-Institute, Institute for Plant Protection in Horticulture and
Forests, Münster, DEU
10:00 Detection and identification of Rickettsia based on fluorescence in situ
OO 05 hybridization
K Aistleitner1,K Stoecker2,H Ge3, AL Richards3, and R Woelfel1
1- Bundeswehr Institute of Microbiology, Bacteriology and Toxinology, Munich, DEU;
2- Bundeswehr Institute of Microbiology, Munich, DEU; 3- Naval Medical Research
Center, Silver Spring, USA
10:15 Southern Kazakhstan as a melting pot for human pathogenic Rickettsiae
OO 06 N Turebekov1, Z Shapiyeva2, L Yeraliyeva3, A Dmitrovskiy4, R Yegemberdiyeva4, K
Abdiyeva1, A Oradova3, A Amirbekov3, Z Kachiyeva3, L Ziyadina2, D Höper5, A
Zhalmagambetova6, S Frey7, J Zinner7, and S Essbauer7
25
Friday
1- Center for International Health, Ludwig-Maximillians-Universität, München, DEU; 2Scientific Practical Center of Sanitary Epidemiological Expertise and Monitoring,
Department of Parasitology, Almaty, KAZ; 3- Research Institute of Applied and
Fundamental Medicine, Kazakh National Medical University, Almaty, KAZ; 4- Kazakh
National Medical University, Department of Infectious Diseases, Almaty, KAZ; 5Friedrich-Loeffler-Institut, Greifswald, Isle of Riems, DEU; 6- Deutsche Gesellschaft
für Internationale Zusammenarbeit, Almaty, KAZ; 7- Bundeswehr Institute of
10:30
Coffee Break
Audimax, 11:00 — 13:00
P
26
Tick-Borne Pathogens in Nature
Chairs: G. Dobler (DEU) and D. Krüger (DEU)
11:00
PO 01
Tick determinants of Powassan virus transmission
ME Hermance1, R Santos1, and S Thangamani1,2
1- University of Texas Medical Branch, Department of Pathology, Galveston, TX,
USA; 2- University of Texas Medical Branch, Galveston National Laboratory,
Galveston, TX, USA
11:30
PO 02
Crimean-Congo Hemorrhagic Fever Virus in Ticks, Kosovo
K Sherifi1, D Cadar2, S Muji3, A Robaj4, S Ahmeti5, X Jakupi6, A Krueger7, and P
Emmerich2
1- Faculty of Agriculture and Veterinary Medicine, University of Prishtina "Hasan
Prishtina", Veterinary Medicine, Prishtina, XXK; 2- Bernhard Nocht Institute for
Tropical Medicine, Hamburg, Department of Virology, Hamburg, DEU; 3- Faculty of
Agriculture and Veterinary Medicine, University of Prishtina "Hasan Prishtina",
University of Prishtina "Hasan Prishtina", Prishtina, XXK; 4- Faculty of Agriculture and
Veterinary Medicine, University of Prishtina "Hasan Prishtina", XXK; 5- Clinic of
Infectious Diseases, University Clinical Centre, Prishtina, XXK; 6- National Institute of
Public Health, Department of Microbiology, Prishtina, XXK; 7- Bundeswehr Hospital
Hamburg,Department of Tropical Medicine, Hamburg, DEU
11:45
PO 03
Epidemiology and surveillance of arthropod borne diseases in febrile patients
in Southwestern Tanzania
CD Mangu1, HB Msila1, B Flach2, K Baumann2, L Maboko3, G Dobler2, and N
Heinrich4
1- NIMR-Mbeya Medical Research Center, TB and Emerging Diseases, Mbeya, TZA;
2- Bundeswehr Institute for Microbiology, Virology and Rickettsiology, Munich, DEU; 3
- NIMR-Mbeya Medical Research Center, Center Director, Mbeya, TZA; 4- University
of Munich (LMU), Division for Infectious Diseases and Tropical Medicine, Munich,
DEU
12:00
PO 04
Epidemiological and Molecular Biological Characterization of TBEV in Mongolia
D Tserennorov1, D Höper2, K Binder3, J Zinner4, G Dobler4, B Baigalmaa1, B Uyanga1,
H Scholz5, J Riehm6, D Kiefer7, S Essbauer4, and S Frey4
Friday
1- National Center for Zoonotic Diseases, Ulaanbaatar, MNG; 2- Friedrich-LoefflerInstitute, Institute of Diagnostic Virology, Greifswald, Isle of Riems, Germany; 3Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Oberschleißheim,
DEU; 4- Bundeswehr Institute of Microbiology, Virology & Rickettsiology, Munich,
DEU; 5- Bundeswehr Institute of Microbiology, Bacteriology & Toxinology, Munich,
DEU; 6- Zentrales Institut des Sanitätsdienstes der Bundeswehr, Abteilung II
Veterinärmedizin, Garching, DEU; 7- Ben-Gurion University of the Negev, The Jacob
Blaustein Institutes for Desert Research, Midreshet Ben-Gurion, ISR
12:15
PO 05
The South of Kazakhstan is a hotspot for the Siberian Subtype of Tick-borne
encephalitis virus
K Abdiyeva1, N Turebekov1, Z Shapiyeva2, L Ziyadina2, A Dmitrovskiy3, R
Yegemberdiyeva3, L Yeraliyeva3, A Oradova3, Z Kachiyeva3, A Amirbekov3, D Höper4,
A Zhalmagambetova5, J Zinner6, S Essbauer6, and S Frey6
1- Center for International Health, Ludwig-Maximillians-Universität, Munich, DEU; 2Scientific Practical Center of Sanitary Epidemiological Expertise and Monitoring,
Almaty, KAZ; 3- Kazakh National Medical University, Almaty, KAZ; 4- FriedrichLoeffler-Institute, Greifswald, Isle of Riems, DEU; 5- Deutsche Gesellschaft für
Internationale Zusammenarbeit (GIZ), Almaty, KAZ; 6- Bundeswehr Institute of
12:30
PO 06
Phylogenetics of Austrian TBE viruses
M Bestehorn1, L Chitimia-Dobler1, FX Heinz2, and G Dobler1
1- Bundeswehr Institute of Microbiology, Dept of Virology and Rickettsiology, Munich,
DEU; 2- Institute of Virology, Medical University of Vienna, Vienna, AUT
12:45
PO 07
The study of genetic diversity and biological properties of tick-borne
encephalitis virus strains of European subtype isolated in different regions of
Russia
S Tkachev1, I Kozlova2, Y Dzhioev3, M Verkhozina4, E Doroschenko2, O Lisak2, T
Demina5, O Suntsova2, A Paramonov2, A Lyapunov2, A Borisenko2, D Kiselev6, A
Tikunov1, N Tikunova1, V Zlobin7, and D Ruzek8
1 - Institute of Chemical Biology and Fundamental Medicine SB RAS, Laboratory of
molecular microbiology, Novosibirsk, RUS; 2- FSSFE Scientific Centre of Family
Health and Human Reproduction Problems SB RAMS, Laboratory of Molecular
Epidemiology and Genetic Diagnostics, Irkutsk, RUS; 3- FSSFE Scientific Centre of
Family Health and Human Reproduction Problems SB RAMS; Institute of Biomedical
Technology, Irkutsk State Medical University of Russian Ministry of Health, Laboratory
of Molecular Epidemiology and Genetic Diagnostics; Laboratory of Molecular Virology
and Biotechnology, Irkutsk, RUS, 4- Centre for Epidemiology and Hygiene in Irkutsk
region, Department of Virology Research and PCR Laboratory, Irkutsk, RUS; 5Irkutsk State Agricultural University named by A.A. Ezhevsky, Irkutsk, RUS; 6- Irkutsk
State Medical University, Department of Microbiology, Virology and Immunology,
Irkutsk, RUS; 7- Institute of Biomedical Technology, Irkutsk State Medical University of
Russian Ministry of Heath; Irkutsk State Medical University, Laboratory of Molecular
Virology and Biotechnology; Department of Microbiology, Virology and Immunology,
Irkutsk, RUS; 8-Biology Centre of the Academy of Sciences of the Czech Republic;
Veterinary Research Institute, Laboratory of Arbovirology; Department of Virology,
Brno, CZE
ι
13:00
27
Biosecurity Lounge
Visit the Biosecurity Lounge
of the German Partnership Program for Excellence in Biological and Health Security
at the 15th Medical Biodefence Conference
When biosecurity experts meet there’s a lot to talk about. In our Biosecurity Lounge we offer a space for
scientific exchange, networking und informal meetings. And since we know that passionate debates
need powerful thinkers we help you refill your batteries – with a selection of coffee, tea and
refreshments in the lounge.
The German Partnership Program for Excellence in Biological and Health Security is all about
international biosecurity experts connecting. With the goal to minimise the risks associated with
biological substances and pathogens, we offer platforms for exchange, training programs and rooms for
debate. We are convinced that scientific friendships around the world and a qualified, engaged
scientific community are an important contribution towards global biological and health security.
The German Partnership Program for Excellence in Biological
and Health Security is engaged globally
28
Let an exhibition about our work with
our partners inspire you!
A part of our Lounge is an art exhibition that will show you new perspectives on biosafety
and biosecurity as well as on the people working with us on improving biosecurity.
We welcome you at the Biosecurity Lounge throughout the conference hours at the
“Lichthof”-atrium at the 1st floor of the main conference building.
29
Poster Presentations
CP
30
Ebola Outbreak Response
CP 01
Successful Application and Use of Modified Shipping Containers for Laboratory
Diagnostics and Emergency Patient Transport to Support the Ebola Disease
Outbreak Response in West Africa
K van der Horst1, J Coffin1, D Roberts1, D McCampbell1, GW Carter1, P Haney3, J Bogan1,
M Cassler2, D Gray3, J Fair1, and K Yeh1
1- MRIGlobal, Rockville, MD, USA; 2- MRIGlobal, Palm Bay, FL, USA; 3- MRIGlobal,
Kansas City, MO, USA
CP 02
Characterization of a Ebola lateral flow rapid test detecting VP 40
P Miethe1, MN Faly2, HH Söffing3, and AM Gad3
1- FZMB GmbH, Bad Langensalza, DEU; 2- Hospital National Donka, Laboratoire de
Virologie, Conakry, GIN; 3- Senova GmbH, Weimar, DEU
CP 03
Ebolavirus: laboratory countermeasures in Western Australia
TJ Inglis1, G Chidlow2, and AJ Merritt2
1- University of Western Australia, School of Pathology & Laboratory Medicine, C, AUS; 2PathWest Laboratory Medicine, Department of Microbiology, Nedlands, AUS
CP 04
Ebola virus stability in biological specimens during short term storage under
different environmental conditions
B Pályi1, N Magyar1, B Szalai1, Á Farkas1, T Strecker2, and Z Kis1
1- National Center for Epidemiology, National Biosafety Laboratory, Budapest, HUN; 2Philipps University Marburg, Institute of Virology, Marburg, DEU
CP 05
Sorting the wheat from the chaff: cases with and without Ebola in the UK and Sierra
Leone
TJ Brooks1, A Simpson1, E Aarons1, N Bentley2, I Goodfellow3, and AE Semper1
1- PHE, RIPL, Salisbury, GBR; 2- PHE, SMS, Salisbury, GBR; 3- University of Cambridge,
Virology, Cambridge, GBR
CP 06
Delivering a clinical laboratory capability to support two Ebola Virus Disease
Treatment Centres in Sierra Leone
G Fitchett, E Hutley, D McKee, and A Dixon
UK MOD, Centre of Defence Pathology, Birmingham, GBR
CP 07
Ebolavirus outbreak in West Africa – Portuguese laboratory response overview
R Cordeiro, A Pelerito, I Lopes de Carvalho, and S Núncio
National Institute of Health Doutor Ricardo Jorge, Infectious Diseases Department, Lisboa,
PRT
CP 08
High Resolution Molecular Analysis of Patients During the Ebola Outbreak in West
Africa
WA Valdivia-Granda
Orion Integrated Biosciences, New York, USA
DP
DP 01
Application of carrier assays for screening of effective sporicidal disinfectants for
PPE disinfection
K Lemmer, S Howaldt, R Heinrich, and R Grunow
Robert Koch-Institute, Centre for Biological Threats and Special Pathogens (ZBS 2), Berlin,
DEU
DP 02
Disinfection of high-containment laboratories by dry fogging with peracetic acid
J Schinköthe1, S Reiche1, S Diederich2, and JP Teifke1
1- Friedrich-Loeffler-Institut, Department of Experimental Animal Facilities and Biorisk
Management, Greifswald - Insel Riems, DEU; 2- Friedrich-Loeffler-Institut, Institute of Novel
and Emerging Infectious Diseases, Greifswald - Insel Riems, DEU
DP 03
Biosafety Cabinets: Influence of Personnel Activities
T Hinrichs, S Gragert, and M Klein
Berner International GmbH, Elmshorn, DEU
DP 04
Biosafety Cabinets: Performance Envelope Testing
T Hinrichs, S Gragert, and M Klein
Berner International GmbH, , Elmshorn, DEU
DP 05
A heterogeneous population of motile Brucellae out of the frog pond
S Al-Dahouk1, S Köhler2, A Occhialini2, MP Jiménez de Bagüés3, JA Hammerl1, T
Eisenberg4, G Vergnaud5, A Cloeckaert6, MS Zygmunt6, AM Whatmore7, F Melzer8, KP
Drees9, JT Foster9, AR Wattam10, and HC Scholz11
1- Federal Institute for Risk Assessment (BfR), Department of Biological Safety, Berlin,
DEU; 2- Université Montpellier, Centre d’études d’agents Pathogènes et Biotechnologies
pour la Santé (CPBS), CNRS, FRE3689, CPBS, Montpellier, FRA; 3- Unidad de Producción
y Sanidad Animal, Centro de Investigación y Tecnología Agroalimentaria, Instituto
Agroalimentario de Aragón – IA2 (CITA-Universidad de Zaragoza), Zaragoza, ESP; 4Landesbetrieb Hessisches Landeslabor, Gießen, DEU; 5- Université Paris-Saclay, I2BC,
CNRS, CEA, Univ. Paris-Sud, Orsay, FRA; 6- Infectiologie et Santé Publique, INRA,
UMR1282, Nouzilly, FRA; 7- Animal & Plant Health Agency, Addlestone, GBR; 8- FriedrichLoeffler-Institut, German National Reference Centre for Human and Animal Brucellosis,
Jena, DEU; 9- University of New Hampshire, Department of Molecular, Cellular, and
Biomedical Sciences, Durham, NH, USA; 10- Virginia Bioinformatics Institute, Virginia Tech,
Blacksburg, VA, USA; 11- Bundeswehr Institute of Microbiology, , Munich, DEU
DP 06
Biocidal and sporicidal efficacy of peracetic acid against bacterial agents at potential
bioterroristic use. Study on stability of two commercial products: Pathoster® 0,35%
and Pathoster® 0,5%.
A Fasanella1, A Candeliere2, L Antonino2, M Iatarola1, F Tolve1, L Civita1, and E Campese1
1- Istituto Zooprofilattico Sperimentale of Puglia and Basilicata, Anthrax Reference Centre
of ITA, Foggia, ITA; 2- Cerichem Biopharm SRL, Cerignola, ITA
31
32
DP
DP 07
Generation of Legionella Containing Shower Aerosols for the Investigation of the
Possible Infection Process
B Kiwull1, A Wunderlich1, S Walser2, B Bartha3, B Brenner3, S Huber4, C Lück2, C Höller4, C
Herr3, M Seidel1, and R Niessner1
1- TU München, Institute of Hydrochemistry, Chair of Analytical Chemistry, Munich, DEU; 2TU Dresden, Institute of Medical Microbiology and Hygiene, Institute of Virology, Medical
Faculty "C.G. Carus", Dresden, DEU; 3- Occupational and Environmental Health,
Epidemiology, Bavarian Health and Food Safety Authority, Munich, DEU; 4- Hygiene,
Bavarian Health and Food Safety Authority, Munich, DEU
DP 08
Survey of Hepatitis E-Virus in wildlife from military training areas in Germany
HE Anheyer-Behmenburg1,2, K Szabo2,3, U Schotte1, A Binder1, R Johne2, and G Klein3
1- Central Institute of the Bundeswehr Medical Service Kiel, Department of Veterinary
Medicine, Kronshagen, DEU; 2- Federal Institute for Risk Assessment, Unit Food Hygiene
and Virology, Berlin, DEU; 3- University of Veterinary Medicine Hannover, Institute of Food
Quality and Food Safety, Hannover, DEU
DP 09
Distribution of Leptospira spp. in rodents and other small mammals from
Afghanistan
A Mayer-Scholl1, RG Ulrich2, JP Teifke3, N Huber2, E Luge1, and K Nöckler1
1- Federal Institute for Risk Assessment (BfR), Department for Biological Safety, Berlin,
DEU; 2- Friedrich-Loeffler-Institut (FLI), Institute for Novel and Emerging Infectious
Diseases, Greifswald-Insel Riems, DEU; 3- Friedrich-Loeffler-Institut (FLI), Department of
Experimental Animal Facilities and Biorisk Management, Greifswald-Insel Riems, DEU
DP 10
Differentiation of the bacterial living and non-living community in the heterogeneous
matrices of spices and herbs
M Kruse1, N Lehmker2, S Schirmer2, and B Niederwöhrmeier2
1- Bundeswehr Research Institute for Protective Technologies and NBC Protection,
Biological Lab, Munster, DEU; 2- Bundeswehr Research Institute for Protective
Technologies and NBC Protection, B-Detection, Munster, DEU
DP 11
Characteristics of S. typhi carrier status of the people who have recovered from
typhoid fever in the environment of uranium biogeochemical areas
R Toichuev1, N Mambetov2, and A Aitikeeva3
1- Institute of Medical Problems, National Academy of Sciences, Osh, KGZ; 2- Mayluusuu
Sanitary and Epidemiological Control Center, Mayluusuu, KGZ; 3- Nooken Sanitary and
Epidemiological Control Center, Nooken, KGZ
DP 12
The social status of people infected with anthrax in southern region of the Kyrgyz
Republic
S Zholdoshov1, R Toichuev1, and A Lapushkin1
Institute of Medical Problems, National Academy of Sciences, Osh, KGZ
DP 13
Analysis of the broad host range siphovirus BiPBO1 from B. inopinata
JA Hammerl, C Goellner, S Al-Dahouk, K Noeckler, J Reetz, and S Hertwig
Federal institute for Risk Assessment, Biological Safety, Berlin, DEU
DP 14
A novel Brucella species isolated from a dog in Costa Rica
MS Zygmunt1,2, M Gonnet1,2, HC Scholz3, G Vergnaud4, and A Cloeckaert1,2
1- INRA, Nouzilly, FRA; 2- Université Francois Rabelais de Tours, UMR1282 Infectiologie et
Santé Publique, Tours, FRA; 3- Bundeswehr Institute of Microbiology, Munich, DEU; 4CNRS, Orsay, FRA
DP 15
A beaver deceased from tularemia and a high and novel genetic diversity of
Francisella tularensis in Germany
K Heuner1, C Schulze2, K Myrtennäs3, D Jacob1, E Karlsson3, K Große4, P Kutzer2, M
Forsman3 and R Grunow1
1- Centre for Biological Threats and Special Pathogens (ZBS 2), Robert Koch Institute,
Berlin, DEU; 2- Landeslabor Berlin-Brandenburg, Frankfurt (Oder), DEU; 3- CBRN Defence
and Security, Swedish Defence Research Agency (FOI), Umea, SWE; 4- Gesundheits- und
Veterinäramt Stadt Brandenburg, Brandenburg an der Havel, DEU.
DP 16
Screening of heroin for Bacillus anthracis-contamination
B Ahrens1, G Grass2, L Dobrzykowski2, M Wagner3, C Krüger3, U Schleenbecker1, and R
Wölfel2
1- Federal Criminal Police Office, Forensic Science Institute, Wiesbaden, DEU; 2Bundeswehr Institute of Microbiology, Bacteriology and Toxinology, Munich, DEU; 3Bundeswehr Institute of Microbiology, Medical Bio Reconnaissance and Verification,
Munich, DEU
DP 17
Decontamination control of chemical warefare agents (CWA) by using protein
biomarkers
A Kostevic, T Meißner, and B Hülseweh
Bundeswehr Research Institute, Biological Laboratory, Munster, DEU
DP 18
The enemy of my enemy is my friend. Bacillus anthracis specific bacteriophages
A Otter1, J Blaxland2, and LW Baillie2
1- Royal Veterinary College, University of London, Department of Pathology & Pathogen
Biology, London, GBR; 2- Cardiff University, School of Pharmacy and Pharmaceutical
Science, Cardiff, GBR
DP 19
In vivo Hemostasis Performance of Chitosan Bandage Using Swine Model
Y Kuo1 and T Lin2
1- CoreLeader Biotech Co., Ltd, Regulatory and R&D, Taipei, TWN; 2- National TWN
University Hospital, Traumatology, Taipei, TWN
DP 20
Survey for zoonotic pathogens in Norway rat populations from Europe
E Heuser1, S Fischer1, R Ryll1, A Mayer-Scholl2, D Hoffmann3, C Spahr4, C Imholt5, DM
Alfa1, A Fröhlich6, D Lüschow7, R Johne4, B Ehlers8, S Essbauer9, K Nöckler2, and RG
Ulrich1
1- Friedrich-Loeffler-Institute, Institute for Novel and Emerging Infectious Diseases,
33
DP
Greifswald, DEU; 2- Federal Institute for Risk Assessment, Department for Biological
Safety, Berlin, DEU; 3- Friedrich-Loeffler-Institute, Institute of Diagnostic Virology,
Greifswald, DEU; 4- Federal Institute for Risk Assessment, NRL for Monitoring
Bacteriological and Viral Contamination of Bivalve Molluscs, Berlin, DEU; 5- Julius KühnInstitute, Institute for Plant Protection in Horticulture and Forests, Münster, DEU; 6Friedrich-Loeffler-Institute, Institute of Epidemiology, Greifswald, DEU; 7- Freie Universität
Berlin, Department of Veterinary Medicine, Institute of Poultry Diseases, Berlin, DEU; 8Robert Koch-Institute, Berlin, DEU; 9- Bundeswehr Institute of Microbiology, Munich, DEU
34
DP 21
The changing faces of Bacillus anthracis in soil
M Sahin1, C Cooper2, F Büyük3, Ö Celebi3, E Celik3, A Gülmez Saglam3, S Otlu3, and L
Baillie4
1- Kafkas University, Department of Microbiology, Veterinary Faculty, Kars, TUR; 2University, Stockholm, The Wenner-Gren Institute, Department of Molecular Biosciences,
Stockholm, SWE; 3- Kafkas University, Department of Microbiology, Veterinary Faculty,
Kars; 4- Cardiff University, Cardiff School of Pharmacy and Pharmaceutical Sciences,
Cardiff, GBR
DP 22
The effect of relief peculiarities on the spread of B. anthracis in Jalal-Abad Province
of the Kyrgyz Republic
R Toichuev1, S Zholdoshov1, N Toichuev1, L Zhilova1, A Lapushkin1, A Aitikeeva2, and N
Mambetov3
1- Institute of Medical Problems, National Academy of Sciences, Osh, KGZ; 2- Nooken
Sanitary and Epidemiological Control Center, Nooken, KGZ; 3- Mayluusuu Sanitary and
Epidemiological Control Center, Mayluusuu, KGZ
EP
Emerging Zoonotic Infections
EP 01
Inhomogeneous distribution of Puumala virus in South-West Germany
S Drewes1, H Turni2, UM Rosenfeld1, A Obiegala3, P Straková1, C Imholt4, E Glatthaar5, K
Dressel6, M Pfeffer3, J Jacob4, C Wagner-Wiening7, and RG Ulrich1
1- Friedrich-Loeffler-Institut, INNT, Greifswald - Insel Riems, DEU; 2- Stauss & Turni
Gutachterbüro, Tübingen, DEU; 3- University Leipzig, Veterinärmedizinische Fakultät,
Institut für Tierhygiene und Öffentliches Veterinärwesen, Leipzig, DEU; 4- Julius KühnInstitute, Federal Research Centre for Cultivated Plants, Institute for Plant Protection in
Horticulture and Forests, Vertebrate Research, Münster, DEU; 5- Universität Freiburg,
Forstzoologisches Institut, Arbeitsbereich Wildtierökologie und Wildtiermanagement,
Freiburg, DEU; 6- sine-Institut gGmbH, Munich, DEU; 7- Landesgesundheitsamt BadenWürttemberg, Referat 95 - Epidemiologie und Gesundheitsberichterstattung,
Sachgebietsleitung: Infektionsepidemiologische Meldesysteme (SG4), Stuttgart, DEU
EP 02
Zoonotic Parapoxvirus infection associated with game animals in the Tyrol region of
Austria and Italy
HP Huemer1, A Zobl2, A Windisch2, W Glawischnig3, N Romani4, M Büttner5, and M
Kitchen4
1- AGES- Austr.Agency f.Health & Food Sefety, IMED, Vienna, AUT; 2- Med.U.Innsbruck,
Hygiene/Microbiology, Innsbruck, AUT; 3- AGES, Inst.f.Vet.Med., Innsbruck, AUT; 4Med.U.Innsbruck, Dermatology, Innsbruck, AUT; 5- LGL-Bavarian Health and Food Safety
Authority, Dpt.Animal Health, Oberschleissheim, DEU
EP 03
Monitoring of shrew-borne Seewis hantavirus in Germany
MM Dafalla
FLI, Institute of Novel and Emerging Infectious Diseases (INNT), Greifswald, DEU
EP 04
Horses and dogs sentinels of West Nile virus circulation in Chad
JL Marié1, B Davoust2, M Maquart3, O Carette4, and I Leparc-Goffart3
1- Working Group on Animal Epidemiology, Regional Medical Command, Toulon, FRA; 2Research Unit on Emerging Infectious and Tropical Diseases (URMITE), Marseille, FRA; 3Centre National de Référence des Arbovirus, Equipe Résidente de Recherche en
Infectiologie Tropicale (ERRIT), Institut de recherche Biomédicale des Armées, Marseille,
FRA; 4- Antenne vétérinaire de Paris, Garde Républicaine, Paris, FRA
EP 05
Life-Threatening Dobrava-Belgrade Virus Infections in Europe
DH Kruger1, EA Tkachenko2, VG Morozov3, YV Yunicheva4, OM Pilikova5, G Malkin2, AA
Ishmukhametov2, P Heinemann1, PT Witkowski1, B Klempa1, and TK Dzagurova2
1- Charité School of Medicine, Virology, Berlin, DEU; 2- Chumakov Institute of Poliomyelitis
and Viral Encephalitides, Moscow, RUS; 3- Medical State University, Samara, RUS; 4- AntiPlague Stations, Sochi, RUS; 5- Anti-Plague Stations, Novorossiysk, RUS
EP 06
Infection of Human Pulmonary Cells with Old World Hantaviruses
A Müller1, A Baumann1, S Essbauer2, M Zeier1, and E Krautkrämer1
1- University of Heidelberg, Department of Nephrology, Heidelberg, DEU; 2- Bundeswehr
Institute of Microbiology, Department of Virology & Rickettsiology, Munich, DEU
FP
FP 01
Whole genome sequence analysis suggests that a remarkable expansion of Bacillus
anthracis occurred in France during the Hundred Years War with England
G Vergnaud1, G Girault2, S Thierry2, C Pourcel1, N Madani2, and Y Blouin3
1- University Paris-Saclay, I2BC, Orsay, FRA; 2- University Paris-Est, ANSES, MaisonsAlfort, FRA; 3- DGA, NRBC, Vert-le-Petit, FRA
FP 02
3rd generation long read sequencing as basis for human diagnostics
M Droege
Roche Diagnostics International Ltd., Rotkreuz, CHE
35
36
FP
FP 03
MinIONTM-Sequencing– A new approach for rapid diagnostics in the field?
MH Antwerpen, E Georgi, P Vette, GH Genzel, and M Walter
Bundeswehr Institute of Microbiology, Munich, DEU
FP 04
Identification of pathogen sequences in NGS datasets
A Andrusch1, PW Dabrowski2, J Klenner1, and A Nitsche1
1- Robert Koch Institute, ZBS 1 - Centre for Biological Threats and Special Pathogens:
Highly Pathogenic Viruses, Berlin, DEU; 2- Robert Koch Institute, JRG 4 - Junior Research
Group: Bioinformatics, Berlin, DEU
FP 05
Separation of foreground and background reads in mixed NGS datasets
S Tausch1, BY Renard2, A Nitsche1, and PW Dabrowski2
1- Robert Koch Institute, ZBS 1 - Centre for Biological Threats and Special Pathogens:
Highly Pathogenic Viruses, Berlin, DEU; 2- Robert Koch Institute, JRG 4 - Junior Research
Group: Bioinformatics, Berlin, DEU
FP 06
Phylogenetic Analysis of Crimean-Congo Hemorrhagic Fever Virus RNA Strains from
South Kazakhstan
P Deryabin1, Y Sansyzbayev1, T Nurmakhanov1, V Berezin2, A Shevtsov3, A Vilkova1, O
Yeskhojayev1, R Sailaubekuly1, M Kulyomin1, and L Atovulayeva1
1- M. Aikimbayev Kazakh Scientific Center of Quarantine and Zoonotic Diseases, Almaty,
KAZ; 2- Institute of Microbiology and Virology, Almaty, KAZ; 3- National Center for
Biotechnology, Astana, KAZ
FP 07
Genotyping of Brucella species by SNPs analysis
M Ancora1, R De Santis2, A Anselmo2, M Orsini1, F De massis1, S Fillo2, K Zilli1, A
Fortunato2, A Palozzi2, B Gentile2, A Ciammaruconi2, E Di Giannatale1, C Cammà1, and F
Lista2
1- Istituto Zooprofilattico Sperimentale Teramo, Teramo, ITA; 2- Centro Studi e Ricerche di
Sanità e Veterinaria Esercito Italiano, Roma, ITA
FP 08
Assessing congruence in SNP genotypes determined from CLC Genomics
Workbench and Life Technologies HID SNP Genotyper
KA Meiklejohn, and JM Robertson
FBI Laboratory, CFSRU, Quantico, VA, USA
FP 09
16S Metagenomics for Identification of Bacterial Genotypes in Voles
KA Koskela1, L Kalin-Mänttäri1, H Hemmilä1, PM Kinnunen2, P Auvinen3, J Niemimaa4, H
Henttonen4, and S Nikkari1
1- Centre for Military Medicine, Research and Development Department, Helsinki, FIN; 2Finnish Defence Forces, Defence Command FIN, Helsinki, FIN; 3- University of Helsinki,
Institute of Biotechnology, Helsinki, FIN; 4- Natural Resources Institute FIN, Vantaa, FIN
FP 10
Genome-wide comparison of Cowpox viruses reveals a new clade related to Variola
virus
L Schrick1, PW Dabrowski1, A Radonić1, A Kurth2, and A Nitsche1
1- Robert Koch Institute, Centre for Biological Threats and Special Pathogens 1 - Highly
Pathogenic Viruses, Berlin, DEU; 2- Robert Koch Institute, Centre for Biological Threats and
Special Pathogens 5 - Biosafety Level 4 Laboratory, Berlin, DEU
FP 11
Bioinformatic search and screening of phages and plasmids via spacer sites of
Yersinia pesudotuberculosis YPIII CRISPR/CAS System
FP Peretolchina1, YP Dzhioev1, AY Borisenko1, AI Paramonov1, EA Voskresenskaya2, LA
Stepanenko1, NE Zelinskaya1, OV Kolbaseeva 1, and VI Zlobin1
1- Irkutsk State Medical University, Irkutsk, RUS, Irkutsk, RUS; 2- Pasteur Institute of
Epidemiology and Microbiology, Saint-Petersburg, RUS, Saint-Petersburg, RUS
FP 12
Whole genome core gene typing of Bacillus anthracis
MC Walter, G Grass, and MH Antwerpen
FP 13
Whole genome analysis of endospore-forming bacteria isolated from heroin
J Kalinowski1, L Dobrzykowski2, B Ahrens3, A Winkler1, A Al-Dilaimi1, D Wibberg1, M
Wagner4, U Schleenbecker3, R Wölfel2, and G Grass2
1- Bielefeld University, Center for Biotechnology, Bielefeld, DEU; 2- Bundeswehr Institute of
Microbiology, Bacteriology and Toxinology, Munich, DEU; 3- Federal Criminal Police Office,
Forensic Science Institute, Wiesbaden, DEU; 4- Bundeswehr Institute of Microbiology,
Medical Bio Reconnaissance and Verification, Munich, DEU
GP
GP 01
The German Academy for Crisis Management, Emergency Planning and Civil
Protection – a nationally and internationally recognized CBRN Training Center
MV Weber, G Uelpenich, J Kaempen, and D Friedrich
Federal Office of Civil Protection and Disaster Assistance, Academy for Crisis Management,
Emergency Planning and Civil Protection, Bad Neuenahr – Ahrweiler, DEU
GP 02
Comparison of NATO AMedP-7.5 Biological Casualty Estimates
CA Curling, and SM Oxford
Institute for Defense Analyses, Strategy, Forces and Resources Division, Alexandria, VA,
USA
GP 03
Open Source Tools for the Assessment of Compliance with the BWC
M Himmel, and G Jeremias
Research Group for Biological Arms Control, University of Hamburg / ZNF, Hamburg, DEU
37
38
GP
GP 04
Animal sentinel systems for biohazard risk assessment in French armed forces
S Watier-Grillot1, B Davoust2, J Demoncheaux3, R Michel1, and J Marié4
1- Army Center for Epidemiology and Public Health Center, Health surveillance, Marseille,
FRA; 2- University of Aix-Marseille - Faculty of Medicine, Research Unit of Emerging
Infections and Tropical Diseases - UMR CNRS 7278 IRD 198 INSERM 1095, Marseille,
FRA; 3- Central Direction of French Army Health Service, Health operational headquarters,
Paris, FRA; 4- Regional Direction of French Army Health service, Working group on Animal
Epidemiology, Toulon, FRA
GP 05
The US European Command Counter Bio-Threats Cell
JA Steele, and KC Allen
U.S. European Command, Counter Bio-Threats Cell, Stuttgart, DEU
GP 06
Food defense concept and application to French army
S Watier-Grillot1, J Demoncheaux2, R Lamand3, R Michel1, and O Cabre4
1- Army Center for Epidemiology and Public Health Center, Health surveillance, Marseille,
FRA; 2- Central Direction of French Army Health Service, Health operational headquarters,
Paris, FRA; 3- French Army Health Service, Veterinary Public Health Unit, Paris, FRA; 4Technical Inspectorate of French Army Veterinary Services, Quality Cell, Paris, FRA
GP 07
RIGEL: Analysis System for Microbial Attribution, Bioforensics and Biosurveillance
WA Valdivia-Granda
Orion Integrated Biosciences, New York, USA
GP 08
Quality Assurance of BSL3 laboratory capacity in Sweden
T Boskani1, M Granberg2, S Frosth3, S Bereczky1, and C Flink4
1- Public Health Agency of SWE, Stockhom, SWE; 2- Swedish Defence Research Agency,
Umeå, SWE; 3- National Veterinary Institute, Uppsala, SWE; 4- National Food Agency,
Uppsala, SWE
GP 09
The European Network on Highly Pathogenic Infectious Agents
R Grunow1, A Di Caro2, D Jacob1, C Nisii2, A Rohleder1, and G Ippolito2 on behalf of the
EMERGE partners3
1- Robert Koch Institute, Centre for Biological Threats and Special Pathogens (ZBS 2),
Berlin, DEU; 2- Spallanzani National Institute for Infectious Diseases, Virology Department,
Rome, ITA; 3- http://www.emerge.rki.eu, EU, EU
GP 10
Joint Action EMERGE: Efficient response to highly dangerous and emerging
pathogens at EU level
D Jacob1, A Sandra1, A Di Caro2, C Nisii2, B Bartolini2, A Rohleder1, G Ippolito2, and R
Grunow1 on behalf of the EMERGE partners3
1- Robert Koch-Institut, Centre for Biological Threats and Special Pathogens, Highly
Pathogenic Microorganisms (ZBS 2), Berlin, DEU; 2- L. Spallanzani National Institute for
Infectious Diseases, Virology Department, Rome, ITA; 3- http://www.emerge.rki.eu, EU, EU
GP 12
New approaches and new intentions against biological attacks⁄threats
V Radosavljevic1,2, and G Belojevic3
1- Military Academy, University of Defense, Belgrade, SRB; 2- Medical Corps Headquarters,
Ministry of Defence, Belgrade, SRB; 3- University of Belgrade, Institute of Hygiene and
Medical Ecology, Belgrade, SRB
GP 13
Strengthening Health and Biosecurity in Tanzania by Biodetection Capacity Building
A Katz1, Z Makondo2, J Masambu2, F Mramba2, and S Nikkari1
1- Center for Biothreat Preparedness and for Military Medicine, Finnish Defence Forces,
Helsinki, FIN; 2- TZA Veterinary Laboratory Agency, Ministry of Agriculture, Livestock and
Fisheries, Dar es Salaam, TZA
GP 14
National Brucella strain collection maintenance standard development accordance
with the European requirements for biosafety and biosecurity
BT Stegniy1, OV Obukhovska2, AP Gerilovych3, AI Zavgorodniy2, and MS Mandygra1
1- NSC IECVM, Kharkiv, UKR; 2- NSC IECVM, Brucellosis and tuberculosis, Kharkiv, UKR;
3- NSC IECVM, Molecular Epidemiology, Kharkiv, UKR
GP 15
International cooperation helps to reduce biological threats
NT Usenbaev, and AK Dzhaparova
The Center of Quarantine and Especially Dangerous Infections, Bishkek, KGZ
HP
HP 01
Update from the German Brucella reference laboratory
M Pfalzgraf, B Thoma, P Vollmar, H Scholz, L Zöller, and S Zange
HP 02
Plague suspected case in Aktobe Region of Kazakhstan 2014
AM Dmitrovskiy1, AZ Murzagaliyeva2, GD Zhumagaliyeva3, MS Kurmangazin2, IN
Musabekova3, and ZE Bekenov4
1- Kazakh National Medical University, Infectious Diseases, Almaty, KAZ; 2- Western-KAZ
Medical University, Epidemiology, Aktobe, KAZ; 3- Western-KAZ Medical University,
Pediatric Infectious Diseases, Aktobe, KAZ; 4- Aktobe Anti Plague Station, Aktobe, KAZ
HP 03
Coxiella burnetii infection in Latvia in 2012-2015
J Storozenko1, T Kolupajeva1, G Pakarna1, N Zamjatina1, A Drabovics1, B Rozentale2, and
A Brila3
1- Latvian Center of Infectious Diseases, National Microbiology Reference Laboratory, Riga,
LVA; 2- Latvian Center of Infectious Diseases, Riga, LVA; 3- The Centre for Disease
Prevention and Control of Latvia, Epidemiology, Riga, LVA
HP 04
Clinical characteristics of anthrax disease in southern region of the Kyrgyz Republic
S Zholdoshov
Institute of Medical Problems, National Academy of Sciences, Osh, KGZ
39
HP
40
HP 05
A complicated Pneumonic Plague with MDR-bacterial Co-Infection in Madagascar
V Andrianaivoarimanana1, E Bertherat2, C Rogier3, and M Rajerison1
1- Institut Pasteur de Madagascar, Plague Unit, Antananarivo, MDG; 2- World Health
Organization, Department of Pandemic and Epidemic Diseases, Geneva, CHE; 3- Institut
Pasteur de Madagascar, Antananarivo, MDG
HP 06
Probable case of Hanta Virus Infection (Hemorrhagic Fever with Renal Syndrome) in
Aktobe Region of Kazakhstan, 2015
AM Dmitrovskiy1, MS Kurmangazin2, IN Musabekova2, AZ Murzagaliyeva3, ZE Bekenov4,
and MG Nurgaliyeva5
1- Kazakh National Medical University, Infectious Diseases, Almaty, KAZ; 2- Western-KAZ
Medical University, Infectious diseases, Aktobe, KAZ; 3- Western-KAZ Medical University,
Epidemiology, Aktobe, KAZ; 4- Aktobe Anti Plague Station, Aktobe, KAZ; 5- Aktobe
Infectious Hospital, Aktobe, KAZ
HP 07
Severe Outbreak amongst Soldiers caused by Salmonella
JM Riehm1, P Simoes2, M Hergenroether1, J Oltersdorf3, U Messelhaeuser4, W Rabsch5, P
Joo6, and S Sauer1
1- Central Institute of the Bundeswehr Medical Service, Bacteriology, Munich, DEU; 2- POR
military, Lissabon, PRT; 3- Central Institute of the Bundeswehr Medical Service,
Bacteriology, Mainz, DEU; 4- Landesuntersuchungsamt Bayern, Munich, DEU; 5- RobertKoch Institute, Wernigerode, DEU; 6- HUN military, Budapest, HUN
IP
Outbreak Management: “Ready or Not - Here I Come“
IP 01
Field investigation of arboviruses in Australia
TJ Inglis1, AJ Merritt1, and A Levy2
1- University of Western AUS, School of Pathology & Laboratory Medicine, Crawley, AUS; 2
- PathWest Laboratory Medicine, Department of Microbiology, Nedlands, AUS
IP 02
CCHF Exposure of Healthcare Professionals in Turkey; How Could We Use This
Experience For Ebola?
S Sezigen1, K Eyison1, L Kenar1, and A Oztuna2
1- GMMA Institýte of Health Sciences, Medical CBRN Defense, Ankara, TUR; 2- GMMA,
Medical Genetics, Ankara, TUR
IP 03
Field based multiplex detection of biothreat agents
C Pöhlmann, and T Elßner
Bruker Daltonik GmbH, Application CBRNE, Leipzig, DEU
IP 04
The mobile suitcase laboratory: A tool for the rapid detection of emerging and
endemic infectious disease
A Abd el Wahed1, P Patel2, O Faye3, MA Shalaby4, M Niedrig5, C Czerny1, AA Sall3, FT
Hufert6, and M Weidmann7
1- Georg-August-University, Division of Microbiology and Animal Hygiene, Goettingen,
DEU; 2- TIB MOLBIOL Syntheselabor GmbH, Berlin, DEU; 3- Pasteur Institute, Arbovirus
unit, Dakar, Senegal; 4- Cairo University, Faculty of Veterinary Medicine, Department of
Virology, Giza, Egypt; 5- Robert Koch Institute, Berlin, DEU; 6- Brandenburg Medical School
Fontane, Senftenberg, DEU; 7- University of Stirling, Institute of Aquaculture, Stirling,
Scotland, GBR
IP 05
After Ebola: Moving forward on preparedness for unusual disease outbreaks
I Hunger
Robert Koch Institute, ZBS, Berlin, DEU
IP 06
Verification of the mobile qPCR device Razor Ex ("The 10®" Pouch)
K Keeren1, T Muzeniek1, S Lenerz2, R Grunow3, D Brigitte4, and A Nitsche1
1- Robert Koch-Institute, ZBS 1, Berlin, DEU; 2- Federal Office of Civil Protection and
Disaster Assistance, Bonn, DEU; 3- Robert Koch-Institute, ZBS 2, Berlin, DEU; 4- Robert
Koch-Institute, ZBS 3, Berlin, DEU
IP 07
CBRN Sampling Equipment - From Research via development to practical training –
an integrative approach
G Uelpenich1, and N Derakshani2
1- Federal Office of Civil Protection and Disaster Assistance, Academy for Crisis
Management, Emergency Planning and Civil Protection, Bad Neuenahr - Ahrweiler, DEU; 2Federal Office of Civil Protection and Disaster Assistance, Bonn, DEU
IP 08
Assessing the Impact of Emerging Infectious Diseases on Military Operations
JK Burr, and RL Cubeta
Institute for Defense Analyses, Strategy, Forces, and Resources Division, Alexandria,
Virginia, USA
IP 09
Assessment of risks of infection of people and animals at contact with natural (the
soil foci) or artificial (laboratory) of anthrax reservoirs
L Lukhnova, A Bakhyt, L Nekrassova, T Meka-Mechenko, V Kazakov, U Izbanova, and V
Sushchikh
The Kazakh Scientific Center of Quarantine and Zoonotic Diseases named after Masgut
Aikimbaev,Almaty, KAZ
´
IP 10
The EFFO project: Linking micro and macro levels to prepare health care workers
(HCW) for outbreak situations by transcultural training and networking
L Verbeek1, P Kabore2, M Mendy3, R Kabore2, R Ellwanger1, Z Kolobaric1, and S Gies4
1- Robert Koch Institute, Centre for Biological Threats and Special Pathogens, Berlin, DEU;
2- OCADES Caritas Burkina, Ouagadougou, BFA; 3- Association Nationale des Postes de
Santé Catholique du Sénégal (ANPSCS), Dakar, SEN; 4- Medical Mission Institute
Würzburg, Würzburg, DEU
41
42
JP
JP 01
Compact Systems for Automated Enrichment and Detection of Biothreats at Point-ofuse
R Himmelreich, M Bassler, R Gransee, C Schwindt, and K Potje-Kamloth
Fraunhofer ICT-IMM, Analytics and Sensorics, Mainz, DEU
JP 02
Ebolavirus proficiency test within the National Laboratory Network for Diagnostics of
BT-relevant Agents (NaLaDiBA)
K Keeren1, S Becker2, S Günther3, H Ellerbrok1, M Panning4, M Eiden5, J SchmidtChanasit3, M Eickmann2, M Monazahian6, B Hülseweh7, B Thoma8, R Oehme9, and A
Nitsche1
1- Robert Koch-Institute, ZBS 1, Berlin, DEU; 2- Institute of Virology, Philipps University,
Marburg, DEU; 3- Bernhard Nocht Institute, Hamburg, DEU; 4- University Hospital, Virology,
Freiburg, DEU; 5- Friedrich Loeffler Institute, Greifswald, Island of Riems, DEU; 6- Lower
Saxony State Health Office, Hannover, DEU; 7- Bundeswehr Research Institute for
Protective Technologies and NBC Protection (WIS), Munster, DEU; 8- Bundeswehr Institute
of Microbiology, Munich, DEU; 9- Baden-Württemberg State Health Office, Stuttgart, DEU
JP 03
Rapid, Reliable and Easy On-Site Identification of Biological Threats
S Ziewer-Arndts
analyticon instruments Gmbh, Rosbach, DEU
JP 04
A comparison of fluorescence in situ hybridization and quantitative RT-PCR for the
detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis
S Mantel1, K Aistleitner1, K Stoecker2, and R Wölfel1
1- InstMikroBioBw, Division for Bacteriology and Toxinology, Munich, DEU; 2InstMikroBioBw, Department for Med. Bio Reconnaissance and Verification, Munich, DEU
JP 05
Validation of a novel Bacillus anthracis PCR Kit within the National Laboratory
Network for Diagnostic of BT-relevant Agents (NaLaDiBA)
K Keeren1, S Ölschläger2, M Elschner3, S Klee4, B Hülseweh5, R Konrad6, G Grass7, M
Monazahian8, R Oehme9, and A Nitsche1
1- Robert Koch-Institute, ZBS 1, Berlin, DEU; 2- altona Diagnostics GmbH, , Hamburg,
DEU; 3- Friedrich Loeffler Institute, Jena, DEU; 4- Robert Koch-Institute, ZBS 2, Berlin,
DEU; 5- Bundeswehr Research Institute for Protective Technologies and NBC Protection
(WIS), Munster, DEU; 6- Bavarian Health and Food Safety Authority, Oberschleißheim,
DEU; 7- Bundeswehr Institute of Microbiology, Munich, DEU; 8- Lower Saxony State Health
Office, Hannover, DEU; 9- Baden-Württemberg State Health Office, Stuttgart, DEU
JP 06
An microarray-based platform for the multiplexed analysis of immunoprofiles for
early differential diagnosis of infectious diseases
R Sekul
PEPperPRINT GmbH, F&E, Heidelberg, DEU
JP 07
Development of a real time microwave-enhanced rapid (~5 minutes) detection assay
for genomic Bacillus anthracis
LT Joshi1, J Lees2, A Porch2, R Probert1, T Connor3, and L Baillie1
1- Cardiff University, School of Pharmacy and Pharmaceutical Sciences, Cardiff, GBR; 2Cardiff University, School of Engineering, Cardiff, GBR; 3- Cardiff University, School of
Biosciences, Cardiff, GBR
JP 08
Using rapid diagnostics to identify causes of febrile illnesses other than Ebola Virus
Disease at a military Ebola Treatment Unit in Sierra Leone
MK Oshea1, K Clay1, T Fletcher1, M Bailey1, and E Hutley2
1- Royal Centre for Defence Medicine, Academic Department of Military Medicine,
Birmingham, GBR; 2- Royal Centre for Defence Medicine, Centre for Defence Pathology,
Birmingham, GBR
JP 09
Influence of different blood collection tubes on virus diagnostics
J Klenner, C Kohl, and A Nitsche
Robert Koch Institute, ZBS 1 - Highly Pathogenic Viruses, Berlin, DEU
JP 10
Rapid detection of viral infections by use of a novel optical biosensor technology
D Vollandt1, P Patel1, P Prüger1, G Proll1, F Pröll2, and M Niedrig1
1- Robert Koch Institute, Center for Biological Threats and Special Pathogens 1, Highly
Pathogenic Viruses, Berlin, DEU; 2- Biametrics GmbH, Tübingen, DEU
JP 11
Rapid detection of ESBL-producing bacteria in irrigation water by DNA microarrays
S Schaefer1, G Valenza2, D Calomfirescu3, S Huber3, C Höller3, R Niessner1, and M Seidel1
1- Technical University of Munich, Chair of Analytical Chemistry and Institute of
Hydrochemistry, Munich, DEU; 2- Bavarian Health and Food Safety Authority, Erlangen,
DEU; 3- Bavarian Health and Food Safety Authority, Oberschleissheim, DEU
JP 12
Prepared for the unusual – fast exchange of database entries for strengthening
MALDI-TOF MS diagnostics on the example of Streptobacillus
J Rau1, and T Eisenberg2
1- Chemisches und Veterinäruntersuchungsamt Stuttgart, Fellbach, DEU; 2- Landesbetrieb
Hessisches Landeslabor, Gießen, DEU
JP 13
Using MALDI-TOF for Genetically Altered Vibrio cholerae Elitor Variants Detection
ZY Khunkheeva1, LV Mironova1, SV Balakhonov2, and MV Afanasev1
1- Irkutsk Antiplague Research Institute of Rospotrebnadzor, Laboratory of Cholera, Irkutsk,
RUS; 2- Irkutsk Antiplague Research Institute of Rospotrebnadzor, Microbiological
Department, Irkutsk, RUS; 3- Irkutsk Regional Clinical Advisory-Diagnostic Centre,
Department of Laboratory Diagnostics, Irkutsk, RUS
JP 14
Performance evaluation of an IgG capture and an IgM µ-capture Chikugunya ELISA
with regards to different strains and regions
H Duchmann, and C Flechsig
NovaTec Immundiagnostica GmbH, Dietzenbach, DEU
43
44
JP
JP 15
Verification and Validation of three RealStar® RT-PCR Kits for Parallel Detection of
Zika, Chikungunya and Dengue Virus
M Zaruba, H El Halas, M Hess, and S Ölschläger
altona Diagnostics GmbH, Research and Development, Hamburg, DEU
JP 16
Species-specific differentiation of variola, monkeypox, and varicella-zoster viruses by
multiplex real-time PCR assay
RA Maksyutov, EV Gavrilova, and SN Shchelkunov
State Research Center of Virology and Biotechnology VECTOR, Koltsovo, RUS
JP 17
Comparison of four commercial DNA extraction kits for the recovery of Bacillus
thuringiensis spore DNA from spiked powder samples
M Mölsä1, L Kalin-Mänttäri2, E Tonteri1, H Hemmilä1, and S Nikkari1
1- Centres for Military Medicine and for Biological Threat Preparedness, Helsinki, FIN; 2National Institute for Health and Welfare, Helsinki, FIN
JP 18
Molecular tools for the discrimination among homogeneous pathogens: example of
anthrax, brucellosis and tularemia
G Girault, N Madani, M Jay, C Mendy, C Ponsart, and V Mick
ANSES, Animal Health Laboratory, Maisons-Alfort, FRA
JP 19
Implementation of New Diagnostic Immunoassays for Detection of F. tularensis and
Brucella species in the Country of Georgia
M Chubinidze1, L Johnson2, B Jenkins2, J Czarnecki2, and S Tsanava1
1- National Center for Disease Control and Public Health, Tbilisi, GEO; 2- Naval Medical
Research Center, Frederick, USA
JP 20
Point-of-Need Detection of Biological Threats
T van Oordt, O Strohmeier, K Mitsakakis, S Hin, R Zengerle, and F von Stetten
Hahn-Schickard, Freiburg, DEU JP 21
Discovery of Host Biomarkers for Early Diagnosis of Biological Agents
K Willis1, D Donohue2, R Yang3, S Muhie3, R Hammamieh2, M Jett-Templeton2, and S
Ibrahim1
1- Edgewood Chemical Biological Center, Aberdeen Proving Ground, US; 2- U.S. Army
Center for Environmental Health Research, Frederick, US; 3- The Geneva Foundation,
Frederick, US
JP 22
Fast and on-site detection of F. tularensis and Y. pestis with commercial ready-to-use
assays
N Sparding, G Kristiansen, MB Oleksiewicz, NR Steenhard, and KN Olsen
Centre for Biosecurity and Biopreparedness , Statens Serum Institut, Copenhagen, DNK
JP 23
A Selective Solid Growth Medium for Isolating and Differentiating Francisella
tularensis Type A and B subspecies
A Shea, T Abshire, M Wolcott, and D Rozak
USAMRIID, DSD, Frederick, USA
JP 24
Diagnostic SNP-based system for the differentiation of Y. pestis ssp pestis and Y.
pestis ssp pestoides in real time PCR
A Trukhachev1, N Konovalova2, A Vodopianov1, K Blagodatskikh2, D Kuznetsova1, D
Sochivko3, and A Rakin4
1- Antiplague Research Institute, Microbiology of Yersinia pestis, Rostov-on-Don, RUS; 2Antiplague Research Institute, Virology, Rostov-on-Don, RUS; 3- Syntol, Biotechnology,
Moscow, RUS; 4- Max von Pettenkofer-Institute, Microbiology of Yersinia, Munich, DEU
JP 25
Multiplex real-time PCR Assay for the Detection and Differentiation of Poxviruses and
Poxvirus Vectors
T Stellberger1, I Stockmar1, M Haase1, H Meyer2, G Zoeller2, M Pavlovic1, M Büttner1, R
Konrad1, H Lang1, K Tischer3, BB Kaufer3, U Busch1, and A Baiker1
1- Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Gentechnische
Anlagen, Oberschleißheim, DEU; 2- Bundeswehr, Institute of Microbiology, Dep Virology,
Munich, DEU; 3- FU Berlin, Institute of Virology, Berlin, DEU
JP 26
Bacillus cereus spores grown in different media can be differentiated using fatty acid
methyl ester (FAME) analysis and Raman spectroscopy
JR Dettman1, CJ Ehrhardt2, and JM Robertson1
1- FBI Laboratory, CFSRU, Quantico, VA, USA; 2- Virginia Commonwealth University, Dept.
Forensic Sciences , Richmond, VA, USA
JP 27
The “who is who” in electron microscopy: establishing techniques for virological
diagnostics and applied research
S Essbauer, T Hinsel, C Kahlhofer, and J Brohl
Bundeswehr Institute of Microbiology, Dept. Virology & intracellular agents, München, DEU
JP 28
A new TaqMan-based real-time PCR assay for detection of Yersinia subspecies
EN Salomonsson1, P Ågren2, M Wijkander3, J Börjesson4, S Frosth4, J Thelaus 1 and E
Karlsson1
1- The Swedish Defence Research Agency, CBRN - Defence and Security, Umeå, SWE; 2The Swedish National Food Agency, Uppsala, SWE; 3- The Swedish National Institute of
Public Health, Stockholm, SWE; 4- The National Veterinary Institute, Uppsala, SWE
JP 29
Simultaneous identification of biological warefare agents with the BioPlex200-System
C Erdmann, and B Hülseweh
JP 30
Decentralized Molecular Testing — Simplicity Rules
A Wende1, C Engemann2, S Werner1, and C Fischer-Rasokat3
1- QIAGEN GmbH, Hilden, DEU; 2- QIAGEN Leipzig GmbH, Leipzig, DEU; 3- QIAGEN
Lake Constance GmbH, Stockach, DEU
45
JP
JP 31
Molecular detection of hepatitis C virus in high risk population: the military medical
concerns
E Ristanovic1,2, S Radakovic1,2, V Protic-Djokic1, S Atanasievska1, and D Jovanovic1
1- Military Medical Academy, Belgrade, SRB; 2- University of Defence, Belgrade, SRB
JP 32
Creation of polymerase chain reaction protocol for West Nile fever virus detection
AP Gerilovych1, BT Stegniy1, OS Solodiankin1, MY Stegniy2, VI Bolotin1, IO Gerilovych1,
and IV Goraichuk1
1- NSC IECVM, Molecular Epidemiology, Kharkiv, UKR; 2- NSC IECVM, Kharkiv, UKR
KP
46
Microbial Population Genomics
KP 01
Using Full Genome SNP Analysis as a tool to investigate the Epidemiology and
Ecology of Bacillus cereus biovar anthracis
F Zimmermann1,2, C Hoffmann2, K Nowak1,2, S Dupke1, E Couacy-Hymann3, R Grunow1,
S Calvignac-Spencer2, S Klee1, and F Leendertz2
1- Robert Koch-Institute, Centre for Biological Threats and Special Pathogens (ZBS2),
Berlin, DEU; 2- Robert Koch-Institute, Epidemiology of highly pathogenic Microorganisms
(P3), Berlin, DEU; 3- Laboratoire National d’Appui au Développement Agricole (LANADA)/
Laboratoire Central Vétérinaire de Bingerville (LCVB), Department of Virology, Bingerville,
Côte d'Ivoire
KP 02
Integrating the Risk Analysis of Brucella infection in Dairy Herds into Herd
Management Software
A Banai1, and M Banai2
1- Honorary consultant, Helsinki, FIN; 2- Kimron Veterinary Institute, Bacteriology, Bet
Dagan 5025001, ISR
KP 03
Microevolution from a Young Ancestor (M.A.Y.A.) Suggests a Soil-Borne Life Cycle
of Bacillus anthracis
P Braun1, G Grass1, M Hanczaruk1, A Aceti2, A Affuso2, V Rondinone2, L Serrechia2, L
Marino2, B Northoff3, M Schloter4, E Georgi5, MH Antwerpen5, and A Fasanella2
1- Bundeswehr Institute of Microbiology, Bacteriology and Toxinology, Munich, DEU; 2Istituto Zooprofilattico Sperimentale of Puglia and Basilicata, Anthrax Reference Institute
of ITA, Foggia, ITA; 3- Ludwig Maximilians Universität München, Institut für
Laboratoriumsmedizin, Munich, DEU; 4- German Research Center for Environmental
Health, Research Unit for Environmental Genomics, Neuherberg, DEU; 5- Bundeswehr
Institute of Microbiology, Genomics and Bioinformatics, Munich, DEU
KP 04
MLVA genotyping of Brucella abortus and Brucella melitensis in Kazakhstan
E Shevtsova1, A Shevtsov1, P Tarlykov1, Y Ramankulov1, A Jailbekova2, M Syzdykov3, A
Kuznetsov3, A Chsherbakov2, A Kairzhanova1, D Kamalova1, G Abisheva1, S Tyulegenov2,
I Sytnik2, T Karibayev2, and M Filipenko4
1- National Center for Biotechnology, Astana, KAZ; 2- National Reference Center for
Veterinary, Astana, KAZ; 3- M. Aikimbayev Kazakh Scientific Center of Quarantine and
Zoonotic Diseases, Almaty, KAZ; 4- Institute of Chemical Biology and Fundamental
Medicine, Novosibirsk, RUS
KP 05
Canine brucellosis in Brazil: existence of an autochthonous lineage
AF Vicente1, Y Corde1, L Perrot1, MR Mioni2, LB Keid3, VR Salgado4, M Jay1, J Megid2,
and V Mick1
1- Paris-Est University/ANSES, Bacterial Zoonoses Unit, Maisons-Alfort, FRA; 2- FMVZ,
UNESP, Dep. of Veterinary Hygiene and Public Health, Botucatu, BRA; 3- USP, Dep. of
Veterinary Medicine, Pirassununga, BRA; 4- Federal University of Bahia, Salvador, BRA
KP 06
Investigation of dog blood samples for the presence of fastidious micro-organisms
N Abazashvili1, T Giorgadze1, G Katsitadze1, R Arner2, M Kosoy3, and L Malania1
1- National Center for Disease Control and Public Health, Tbilisi, GEO; 2- Metabiota, Inc.,
San Francisco, USA; 3- Division of Vector-Borne Diseases, Centers for Disease Control
and Prevention, Fort Collins, USA
KP 07
Epidemiological Features of Human Anthrax Cases in Mongolia
K Burmaa1, N Tsogbadrakh1, G Ganbileg1, M Darmaa2, and G Davaa2
1- National center for zoonotic diseases, Ulaanbaatar, MNG; 2- Mongolian National
University of Medical Sciences, Ulaanbaatar, MNG
KP 08
Unexpected genomic relationships between Bacillus anthracis strains from
Bangladesh and central Europe
CR Ahsan1, G Grass2, MH Antwerpen3, FI Rume1, and MA Hanczaruk2
1- University of Dhaka, Department of Microbiology, Dhaka, BGD; 2- Bundeswehr Institute
of Microbiology, Department for Bacteriology and Toxinology, Munich, DEU; 3Bundeswehr Institute of Microbiology, Department for Microbial Genomics and
Bioforensics, Munich, DEU
LP
LP 01
Virulence of emerging Bacillus cereus biovar anthracis is determined by toxins and
two types of capsules
SR Klee1, S Dupke1, C Brézillon2, M Haustant2, A Lander1, J Corre2, T Franz1, F
Zimmermann1, FH Leendertz3, M Mock2, R Grunow1, and PL Goossens2
1- Robert Koch-Institut, Centre for Biological Threats and Special Pathogens (ZBS 2),
Berlin, DEU; 2- Institut Pasteur, Pathogénie des Toxi-Infections Bactériennes, Paris, FRA;
3- Robert Koch-Institut, Epidemiology of Highly Pathogenic Microorganisms (P3), Berlin,
DEU
LP 02
Machine Learning Driven Detection of Bacterial Virulence Factors
R Rentzsch, C Deneke, and BY Renard
Robert Koch Institut, NG4, Berlin, DEU
47
48
LP
LP 03
Rapid and sensitive Detection of Staphylococcal Enterotoxins by Immunomagnetic
separation inline-coupled Microarray analysis
A Nistler1, M Sandhu1, R Dietrich2, E Märtlbauer2, T Wittwer3, R Niessner1, and M Seidel1
1- Technical University of Munich, Institute of Hydrochemistry and Chair of Analytical
Chemistry , Munich, DEU; 2- Ludwig Maximilians University of Munich, Hygiene and
Technology of Milk, Munich, DEU; 3- R-Biopharm AG, Darmstadt, DEU
LP 04
Investigations of biological characteristics and patterns of cell death genes during
Langat virus infection of neuroblastoma cell lines
S Essbauer1, K Freimüller1, A Mayer1, P Vollmar1, S Frey1, G Dobler1, and R Kühn2
1- Bundeswehr Institute of Microbiology, Dept. Virology & intracellular agents, München,
DEU; 2- Technical University Munich, AG Molecular Zoology, Freising-Weihenstephan,
DEU
LP 05
Anthrax pore biology: characterization by neutron scattering and application to
cytosolic antisense and siRNA delivery.
S Shorter1, P Dyer1, S Richardson1, L Baillie2, and R Barker3
1- University of Greenwich, Life and Sport Science, Chatham Maritime, GBR; 2- Cardiff
University, School of Pharmacy & Pharmaceutical Science, Cardiff, GBR; 3- University of
Dundee, Dundee, GBR
LP 06
Validation of a mass spectrometry (MS) method capable of detecting and measuring
the activity of ribosome inactivating proteins (RIPs) in complex food and drink
matrices
JM Goss, and JM Robertson
FBI Laboratory, CFSRU, Quantico, VA, USA
LP 07
Novel cell targeting L-ddBCNA antiviral inhibits autophagy in measles virus infected
cells
R Narayan1, L Farleigh1, D Friese2, C McGuigan3, E Sayers3, AT Jones3, and JJ Bugert1
1- Cardiff University, Medical Microbiology and Infectious Diseases, Cardiff, GBR; 2Institute for Microbiology, Ministry of Defence, Munich, DEU; 3- Cardiff University, Cardiff
School of Pharmacy & Pharmaceutical Sciences, Cardiff, GBR
LP 08
A cross-reactive monoclonal antibody raised against recombinant hepatitis E virus
genotype 3 capsid antigen
B Kubickova1, JA Schenk2, K Marcinkeviciute3, J Reetz4, P Dremsek1, PL Tamosiunas3, R
Petraityte-Burneikiene3, JF Drexler5, A Andersson4, D Becher6, MH Groschup1, F Sellrie2,
R Johne4, and RG Ulrich1
1- Friedrich-Loeffler-Institut, Greifswald, DEU; 2- Hybrotec GmbH, Potsdam, DEU; 3Vilnius University, Vilnius, Lithuania; 4- Federal Institute for Risk Assessment, Berlin,
DEU; 5- Universitätsklinikum Bonn, Bonn, DEU; 6- Micromun GmbH, Greifswald, DEU
LP 09
Comparative analysis of the antigenic properties of the tick-borne encephalitis virus
strains used for vaccination
YS Bukin1, YP Dzhioev2, VI Zlobin2, IV Kozlova3, SE Tkachev4, and D Ruzek5
1- Limnological Institute, SB RAS, Irkutsk, RUS; 2- Irkutsk State Medical University,
Irkutsk, RUS; 3- Scientific Center for Problems of Family Health and Human Reproduction,
Irkutsk, RUS; 4- Institute of Chemical Biology and Fundamental Medicine, SB RAS,
Novosibirsk, RUS; 5- Institute of Parasitology, Biology Centre of the Academy of Sciences,
České Budějovice, CZE
LP 10
Eavualtion of humoral immunity against smallpox in Brazilian army CBRN troops
NV Cruz1, RH Peralta2, and C Damaso3
1- Biology Institute of Brazilian Army, Education and Research Division, Rio de Janeiro,
BRA; 2- Fluminense Federal University, School of Medicine, Niterói, BRA; 3- Federal
University of Rio de Janeiro, Biophysics Institute, Rio de Janeiro, BRA
LP 11
The Regional Differences of the Human Immunological Response to Anthrax
Infection
N Chitadze1, M Doganay2, E Parlak3, U Kayabas4, M Parlak3, M Sunnetcioglu5, M
Karahocagil5, and P Baillie6
1- National Center for Disease Control and Public Health, Virology and Molecular Biology,
Tbilisi, GEO; 2- Erciyes University, Kayseri, TUR; 3- Ataturk University, Erzurum, TUR; 4Inonu University, Malatya, TUR; 5- Yuzuncu Yil University, Van, TUR; 6- School of
Pharmacy and Pharmaceutical Sciences College of Biomedical and Life Sciences Cardiff
University, Cardiff, GBR
LP 12
γ-Glytamyl Transpeptidase of Francisella tularensis as drug target for the
development of a new class of anti-infectives
C Daschkin1, Z Sahavi-Ouriaghi1, MH Antwerpen2, H von Buttlar2, G Popowicz4, M
Gerhard1, and H Meyer1
1- Technical University Munich, Institut für medizinische Mikrobiologie, Immunologie und
Hygiene, Munich, DEU; 2- Bundeswehr Institute of Microbiology, Munich, DEU; 3Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt
(GmbH), Institute of Structural Biology, Neuherberg, DEU
LP 13
Computer-Aided Design of Novel Nucleoside Analogues as Dengue Virus Inhibitors.
CM Cima1, JJ Bugert2, and A Brancale1
1- Cardiff University, School of Pharmacy and Pharmaceutical Sciences, Cardiff, GBR; 2Armed Forces Medical Academy, Institute for Microbiology, Munich, DEU
LP 14
Targeted Proteomic Analysis of Abrin
A Myslivcova Fucikova1, J Klimentova1, M Duracova1, J Dresler2, and Z Krocova1
1- University of Defence, Department of Molecular Pathology and Biology, Hradec
Kralove, CZE; 2- Military Health Institute, Praha, CZE
LP 15
Analysis of OPCW relevant toxins
B Hülseweh, and T Meißner
49
50
LP
LP 16
Detection of Clostridium perfringens toxins in complex matrices by mass
spectrometry
M Ďuráčová1, J Klimentová1, V Sheshko1, A Myslivcová Fučíková1, J Dresler2, and Z
Kročová1
1- University of Defense, Department of Molecular Pathology and Biology, Hradec
Králové, CZE; 2- Military Health Institute, Prague, CZE
LP 17
Ricin vs. Abrin – or how to distinguish twins?
AW Weiß, P Vollmar, H von Buttlar, R Wölfel, and MA Hanczaruk
Bundeswehr Institute of Microbiology, Department for Bacteriology and Toxinology,
Munich, DEU
LP18
Sensitive detection of Botulinum Neurotoxin combining affinity enrichment and
enzyme activity detection
H Buttlar, I Mochner, P Kriebs, and R Woelfel
Bundeswehr Institute of Microbiology, Bacteriology and Toxinology, Munich, DEU
LP 19
Improvement of Ricin detection in food chain matrices by affinity enrichment
H Buttlar, M Hanczaruk, P Kriebs, and R Woelfel
Bundeswehr Institute of Microbiology, Bacteriology and Toxinology, Munich, DEU
LP 20
Effects on the structure of the proteins ricin and SEB
M Kruse1, M Winkler2, S Schirmer2, and B Niederwöhrmeier2
1- Bundeswehr Research Institute for Protective Technologies and NBC Protection,
Biological Lab, Munster, DEU; 2- Bundeswehr Research Institute for Protective
Technologies and NBC Protection, B-Detection, Munster, DEU
LP 21
Novel cell targeting L-ddBCNA antiviral inhibits autophagy in measles virus infected
cells.
LJ Farleigh1, R Narayan1, D Friese2, E Sayers1, AT Jones3, C McGuigan3, and JJ Bugert2
1- Cardiff University, Medical Microbiology, Cardiff, GBR; 2- Bundeswehr Institute of
Microbiology, Munich, DEU; 3- Cardiff University, Pharmacy and Pharmaceutical
Sciences, Cardiff, GBR
MP
MP 01
Efficacy assessment of anthrax vaccines
S Charlton1, H Cuthbertson1, K Thomas1, E Hughes1, L Mcinroy1, D Powell1, P Proud1, C
Neil1, K Steeds1, M Matheson2, A England2, S Funnell3, I Taylor4, G Hatch4, and B Hallis1
1- Public Health England, Vaccine Research Group (National Infections Service Porton),
Salisbury, GBR; 2- Public Health England, Immunoassay Group (National Infections
Service Porton), Salisbury, GBR; 3- Public Health England, Biodefense and Preclinical
Evaluation Group, Salisbury, GBR; 4- Public Health England, Biological Investigations
Group, Salisbury, GBR
MP 02
Engeneering of Neutralizing Human Recombinant Antibodies Derived from
Immunoglobulin Libraries binding to Orthopox Virus Envelope Proteins.
US Diesterbeck1, A Frenzel2, H Ahsendorf3, T Schirrmann2, S Dübel2, and CP Czerny3
1- NIH, NIAID, Laboratory of Viral Diseases, Bethesda, USA; 2- Technische Universität
Braunschweig, Institute of Biochemistry, Biotechnology and Bioinformatics, Braunschweig,
DEU; 3- Georg-August-University, Department of Animal Sciences, Göttingen, DEU
MP 03
Recombination between Modified vaccinia virus Ankara-vectored influenza vaccine
and a feline cowpox virus during co-infection and superinfection in Vero cells
DD Canova1, TG Oludotun2, AS Okoli1, Ø Nilssen3, U Moens4, M Tryland5, T Bøhn6, T
Traavik1, B Entler7, and MI Okeke1
1- GenØk-Centre for Biosafety, Virology, GM Viruses and Vaccines, Tromsø, NOR; 2IMC University of Applied Sciences, Medical and Pharmaceutical Biotechnology, Krems,
AUT; 3- UiT The Arctic University of NOR, Clinical Medicine, Tromsø, NOR; 4- UiT The
Arctic University of NOR, Medical Biology, Tromsø, NOR; 5- UiT The Arctic University of
NOR, Arctic and Marine Biology, Tromsø, NOR; 6- GenØk-Centre for Biosafety,
Ecotoxicology, Tromsø, NOR; 7- IMC University of Applied Sciences Krems, Medical and
Pharmaceutical Biotechnology, Krems, AUT
MP 04
Establishment of Processes for the Development of Monoclonal and Polyclonal
Antibodies in the Country of Georgia
T Shutkova1, E Nalbandishvili1, V Kakhadze1, T Deal1, B Jenkins2, J Czarnecki2, and S
Tsanava1
1- National Center for Disease Control and Public Health, Tbilisi, GEO; 2- Naval Medical
Research Center, Frederick, USA
MP 05
A complex approach for development of safe vaccines against human
orthopoxvirus infections
RA Maksyutov, SN Yakubitsky, IV Kolosova, SN Shchelkunov
State Research Center of Virology and Biotechnology "VECTOR”, Koltsovo, Novosibirsk
region, RUS
MP 06
Identification of novel tularemia vaccine candidates
V Sheshko, M Schmidt, and J Stulik
University of Defence, Faculty of Military Health Sciences, Hradec Kralove, CZE
MP 07
Testing of new compounds with potential activity against Mycobacterium
tuberculosis
O Pavliš1, P Kubíèková1, J Roh2, and V Klimešová2
1- Military Health Institute, Department of Biological Defense, Tìchonín, CZE; 2- Charles
University in Prague, Faculty of Pharmacy in Hradec Králové, Hradec Králové, CZE
MP 08
Anthrax Toxin Removal by Fusion Protein Immobilised on New Cryogel Materials
E Lis1, A Leistner1, M Stier1, A Leistner1, and L Baillie2
1- Polymerics GmbH, Berlin, DEU; 2- Cardiff University, School of Pharmacy and
Pharmaceutical Sciences, Cardiff, GBR
51
MP
MP 09
The efficient removal of anthrax toxin from human blood using monoclonal
antibodies immobilized on a disposable polymeric cryogel
G Ingavle1, S Sandeman1, Y Zheng1, S Mikhalovsky1, and L Baillie2
1- University of Brighton, School of Pharmacy and Biomolecular Sciences, Brighton, GBR;
2- Cardiff University, School of Pharmacy and Pharmaceutical Sciences, Cardiff, GBR
MP 10
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection
in dromedary camels
B Haagmans1, J van den Brand1, V Raj1, A Volz2, P Wohlsein3, S Smits1, D Schipper1, T
Bestebroer1, N Okba1, R Fux2, A Bensaid4, D Foz4, T Kuiken1, W Baumgärtner3, J
Segalés4, G Sutter2, and A Osterhaus5
1- Erasmus Medical Center, Department of Viroscience, Rotterdam, NLD; 2- LMU Munich,
Institute for Infectious Diseases and Zoonoses, Munich, DEU; 3- University of Veterinary
Medicine, Department of Pathology, Hannover, DEU; 4- Campus de la Universitat
Autònoma de Barcelona, Centre de Recerca en Sanitat Animal (CReSA), Barcelona, ESP;
5- University of Veterinary Medicine, Center for Infection Medicine and Zoonoses
Research (RIZ), Hannover, DEU
NP
52
Fostering Biosafety for a Safer World
Advanced training session by the German Partnership Program for Excellence
in Biological and Health Security
NP 01
Brucellosis and Q-Fever Infections in Egypt
H El-Adawy, J Klemmer1, F Melzer1, and H Neubauer1
Friedrich Loeffler Institut, Institute of Bacterial Infections and Zoonoses, Jena, DEU
NP 02
Glanders and Brucellosis in Ukraine
MC Elschner1, F Melzer1, R Koziy2, and H Neubauer1
1- Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Institute of
Bacterial Infections and Zoonoses, Jena, DEU; 2- State Scientific Control Institute of
Biotechnology and Strains of Microorganisms, Kiev, UKR
NP 03
Outbreak preparedness in developing countries - Conclusions from a conference,
capacity building workshop and infrastructure adaptation in Mbeya, Tanzania
G Froeschl1, NE Ntinginya2, A Sangare3, P Lawala3, C Mangu2, G Dobler4, N Heinrich1, B
Flach4, A Nsojo3, and T Lennemann1
1- Medical Centre of the University of Munich, Division of Infectious Diseases and Tropical
Medicine, Munich, DEU; 2- National Institute of Medical Research, Mbeya Medical
Research Center, Mbeya, TZA; 3- Mbeya Zonal Referral Hospital, Mbeya, TZA; 4Bundeswehr, Institute of Microbiology, Munich, DEU
NP 04
Tick-borne Encephalitis virus (TBEV) investigation in Georgia
T Jashiashvili1, R Sukhiashvili1, S Thumann2, M Strehle2, R Wölfel2, and P Imnadze1
1- National Center for Disease Control and Public Health (NCDC), Richar G. Lugar Center
for Public Health Research, Tbilisi, GEO; 2- Bundeswehr Institute of Microbiology,
Bacteriology & Toxinology, Munich, DEU
NP 05
German-Georgian Collaboration for Global Health Security
A Gamkrelidze1, P Imnadze1, and R Wölfel2
1- National Center for Disease Control and Public Health, Tbilisi, GEO; 2- Bundeswehr Institute
of Microbiology, Munich, DEU
NP 06
Strengthening Biosafety and Biosecurity in Sudan – an unprecedented cooperation
IE Andernach1, J Wolf2, N Hanschmann1, W Biederbick2, and R Grunow1
1- Robert Koch Institute, Centre for Biological Threats and Special Pathogens - Highly
Pathogenic Microorganisms, Berlin, DEU; 2- Robert Koch Institute, Strengthening Global
Biosecurity, Berlin, DEU
NP 07
The German Partnership Program Supports Biorisk Management in Kazakhstan
S Frey1, Z Shapiyeva2, R Yegemberdiyeva3, A Dmitrovsky3, L Yeralyeva3, N Turebekov4, K
Abdiyeva4, J Zinner1, A Zhalmagambetova5, and S Essbauer1
1- Bundeswehr Institute of Microbiology, Virology & Rickettsiology, Munich, DEU; 2- Scientific
Practical Center of Sanitary Epidemiological Expertise and Monitoring, Parasitology, Almaty,
KAZ; 3- Kazakh National Medical University, Almaty, KAZ; 4- Ludwig-Maximillians-Universität,
Center for International Health, Munich, DEU; 5- Deutsche Gesellschaft für Internationale
Zusammenarbeit (GIZ), Almaty, KAZ
NP 08
Improving biosafety in ministry of health laboratories in Morocco
R Selka1, M Rhajaoui1, and A Maaroufi2
1- National Institut of hygiene, Ministry of Health, Rabat, MAR; 2- Direction of Epidemiology and
fight against diseases, Ministry of Health, Rabat, MAR
NP 09
Crimean-Congo Hemorrhagic Fever Virus Infections in Sub-Saharan Africa: diagnostic
challenges for seroprevalence studies in ruminants
M Mertens, MA Sas, I Schuster, and MH Groschup
Friedrich-Loeffler-Institut, Institute for Novel and Emerging Infectious Diseases, Greifswald-Insel
Riems, DEU
NP 10
Brucellosis in Pakistan
H El-Adawy1, I Khan2, F Melzer1, and H Neubauer1
1- Friedrich Loeffler Institut, Institute for Bacterial Infections & Zoonoses, Jena, DEU; 2-College
of Veterinary and Animal Sciences, Section of Epidemiology and Public Health, Jhang, PAK
NP 11
Experience of our Virology Laboratory (Pasteur Institute Casablanca) during Ebola virus
outbreak in West Africa
J Nourlil1, A Faouzi1, L Anga1, and N El Mdaghri2
1- Institut Pasteur du Maroc, Virology, Casablanca, MAR; 2- Institut Pasteur du Maroc,
Casablanca, MAR
NP 12
Biosafety/ Biosecurity activities of the German Partnership Program in Morocco: Goals
and way forward
O Kysil1, JP Böttcher2, R Selka3, J Nourlil4, L Wakrim4, M Abid4, S Abdelouhab4, N Barakate3, L
Ouaffak3, N El Mdaghri4, M Rhajaoui3, and R Grunow2
1- Robert Koch-Institut, Strengthening Global Biosecurity, Berlin, DEU; 2Robert Koch-Institut, Centre for Biological Threats and Special Pathogens, Berlin, DEU; 3 Institut National d’Hygiène (INH), Rabat, MAR; 4 - Institut Pasteur du Maroc, Casablanca, MAR
53
OP
54
Emerging Diversity of Intracellular Agents
OP 01
Distribution of Tick-Borne Rickettsioses in Mongolia
D Altantogtokh, D Tserennorov, B Bolorchimeg, N Tsogbadrakh, and G Ganbileg
National Center for Zoonotic Diseases, Ulaanbaatar, MNG
OP 02
Chronic Q fever endocarditis in a patient with recurrent aortic valve prosthesis
P Vollmar1, B Thoma1, S Feihl2, U Reischl3, A Hiergeist3, S Bleiziffer4, K Specht5, C
Kahlhofer1, MC Walter1, and D Frangoulidis1
1- Bundeswehr Institute of Microbiology, Munich, DEU; 2- Institute for Medical
Microbiology, Immunology and Hygiene, Technische Universität München, Munich, DEU;
3- Institute of Medical Microbiology and Hygiene, Universitätsklinikum Regensburg, ,
Regensburg, DEU; 4- Department of Cardiovascular Surgery, German Heart Center
Munich, Munich, DEU; 5- Institute of Pathology, Technische Universität München, Munich,
DEU
OP 03
Emerging tularemia in the county of Oslo, Norway
T Hoel1, S Helland2, and O Scheel2
1- Oslo University Hospital, Ulleval, Department of Infectious Diseases, Oslo, NOR; 2Armed Forces Medical Services, Institute of Microbiology, Oslo, NOR
OP 04
The epidemiology of tick-borne rickettsioses in Kazakhstan
L Yeraliyeva1, R Yegemberdiyeva1, A Dmitrovskiy1, Z Shapiyeva2, N Turebekov1, and A
Dushpanova1
1- Kazakh National Medical University, Almaty, KAZ; 2- Scientific Practical Center of
Sanitary Epidemiological Expertise and Monitoring, Almaty, KAZ
OP 05
Rickettsial biodiversity and emerging health risk in France
L Kurzrock1, R Oehme2, P Sebastian1, and U Mackenstedt1
1- Institute of Parasitology, University of Hohenheim, Stuttgart, DEU; 2- State Health
Office Baden-Wuerttemberg, Stuttgart, DEU
OP 06
Rickettsia diversity in small mammals from South Africa
S Essbauer1, M Hofmann1, C Kleinemeier1, and S Matthee2
1- Bundeswehr Institute of Microbiology, Munich, DEU; 2- Stellenbosch University,
Department of Conservation Ecology and Entomology, Matieland, ZAF
OP 07
The Pangenome and Variome of Coxiella burnetii
MC Walter, and D Frangoulidis
OP 08
Do lice deserve their lousy reputation?
S Cutler1, S Moutailler2, and M Vayssier-Taussat2
1- University of East London, School of Health, Sport and Bioscience, London, GBR; 2ANSES, Paris, FRA
PP
PP 01
Detection of Dobrava-Belgrade hantavirus genotype Kurkino in Apodemus agrarius
in Germany during 2009-2015
P Strakova, S Schmidt, M Schlegel, S Drewes, and RG Ulrich
Friedrich Loeffler Institut, Institut für neue und neuartige Tierseuchenerreger , Greifswald,
DEU
PP 02
Lyme Borreliosis in Europe: Trend analysis from 1999 through 2014
C Klier1, S Oconnell2, C Kleinemeier3, and R Smith4
1- Munich, DEU; 2- formerly Health Protection Agency, Southhampton, GBR; 3- LMU
München, Department for Bacteriology, Oberschleißheim, DEU; 4- Public Health UK,
Cardiff, GBR
PP 03
First detection of Ixodes inopinatus north of the Alpian Mountains
L Chitimia-Dobler1, M Bestehorn1, and S Nava2, G. Dobler1
1- Bundeswehr Institute of Microbiology, Dept of Virology and Rickettsiology, Munich,
DEU; 2- INTA, Dept of Parasitology, Rafaela, ARG
PP 04
First detection of Hyalomma rufipes in Germany
L Chitimia-Dobler, M Bestehorn, G Dobler, and S Wölfel
Bundeswehr Institute of Microbiology, Virology & Rickettsiology, Munich, DEU
PP 05
First molecular characterization of a complete E gene of a TBE virus strain from
Bornholm, Denmark
NS Andersen1, R Riess2, L Chitimia-Dobler2, S Skarphédinsson3, PM Jensen4, S Wölfel2,
G Dobler2, and M Bestehorn2
1- Odense University Hospital and Clinical Institute, University of Southern Denmark,
Clinical Center of Emerging and Vectorborne Infections and Research Unit of Clinical
Microbiology , Odense, DNK; 2- Bundeswehr Institute of Microbiology, partner of German
Center of Infection Research (DZIF), Munich, DEU; 3- Odense University Hospital, Clinical
Center of Emerging and Vectorborne Infections, Odense, DNK; 4- University of
Copenhagen, Department of Plant- and Environmental Sciences, Copenhagen, DNK
PP 06
Tick-borne encephalitis in Germany– Actual Situation and Trends
G Dobler
Bundeswehr Institute of Microbiology, Dept of Virology and Rickettsiology, Munich, DEU
PP 07
Clinical and epidemiological characteristics of tick-borne encephalitis in
Kazakhstan
R Yegemberdiyeva1, A Dmitrovskiy1, Z Shapiyeva2, L Yeraliyeva1, N Turebekov1, K
Abdiyeva1, and A Shin1
1- Kazakh National Medical University, Almaty, KAZ; 2- Scientific Practical Center of
Sanitary Epidemiological Expertise and Monitoring, Almaty, KAZ
55
56
PP
PP 08
The unique combined natural foci of tick-borne infections in the Irkutsk region,
Russia
I Kozlova1, O Lisak1, E Doroshchenko1, O Suntsova1, J Savinova1, M Verkhozina2, Y
Dzhioev1, V Rar3, S Tkachev3, T Demina4, A Paramonov1, and V Zlobin5
1- Scientific Centre of Family Health and Human Reproduction Problems, Laboratory of
Molecular Epidemiology and Genetic Diagnostics, Irkutsk, RUS; 2- Centre for Hygiene and
Epidemiology in Irkutsk region, Department of Virology Research and PCR Laboratory,
Irkutsk, RUS; 3- Institute of Chemical Biology and Fundamental Medicine SB RAS,
Laboratory of Molecular Microbiology, Novosibirsk, RUS; 4- Irkutsk State Academy of
Agriculture, Faculty of Veterinary Medicine and Biotechnology, Irkutsk, RUS; 5- Institute of
Biomedical Technology, Irkutsk State Medical University of Russian Ministry of Heath,
Laboratory of Molecular Virology and Biotechnology, Irkutsk, RUS
PP 09
Some Results Spatial Analyze of Distribution I. persulcatus Tick in Mongolia
J Battsetseg, N Uranshagai, and D Tserennorov
National center for zoonotic diseases, Ulaanbaatar, MNG
PP 10
Tick borne-pathogens in ticks infesting humans from Sibiu County, Romania
M Andersson1, G Marga2, L Pricop3, P Tamba3, T Banu4, G Dobler5,6, and L ChitimiaDobler5,6
1- Lund University, Molecular Ecology and Evolution Lab, Lund, SWE; 2- Public Health
Direction, Epidemiological Surveillance and Disease Control Department, Sibiu, ROU; 3Institute for Diagnosis and Animal Health, Molecular Biology, Bucharest, ROU; 4- Institute
for Diagnosis and Animal Health, Epidemiology, Bucharest, ROU; 5- Bundeswehr Institute
of Microbiology, Virology and Rickettiology, Munich, DEU; 6- German Center of Infection
Research (DZIF), Munich
PP 11
The Situation on Tick-borne Dieseases in Kazakhstan
Z Shapiyeva1, R Yegemberdiyeva2, and L Yeraliyeva3
1- SPC SEEM, Epidemiology and Parasitology, Almaty, KAZ; 2- KazNMU, Infectious
Diseases, Almaty, KAZ; 3- KazNMU, Institute of Applied Medicine, Almaty, KAZ
PP 12
Who are you and where are you from? Comparison of Methods for Identification
and Trace-Backing of Vectors
A Nikolic1, L Chitima-Dobler2, G Dobler2, and MH Antwerpen1
1- Bundeswehr Institute of Microbiology, Microbial Genomics and Bioforensics, Munich,
DEU; 2- Bundeswehr Institute of Microbiology, Virology and Rickettsiology, Munich, DEU
PP 13
Molecular survey of tick-borne pathogens in wild boars from Central Italy
M Di Domenico1, C Cammà1, V Curini1, F Dall Acqua1, D Di Sabatino1, and I Pascucci1
Istituto Zooprofilattico Sperimentale, Teramo, ITA
PP 14
Tick screening at military training sites in Austria
M Weiler1, G Duscher2, P Hufnagl3, and J Walochnik4
1- CBRN-Defense School, Korneuburg, AUT; 2- University of Veterinary Medicine,
Institute of Parasitology, Vienna, AUT; 3- AUTn Agency for Health and Food Safet ,
Vienna, AUT; 4- Medical University of Vienna, Institute of Specific Prophylaxis und
Tropical Medicine, Vienna, AUT
PP 15
Establishing of a MALDI-TOF database for identifying African ticks
MH Antwerpen, M Weiß, B Flach, K Baumann, G Dobler, and L Chitima-Dobler
57
General Information
Conference Venue and Date
The Medical Biodefense Conference 2016 will take place from 26th to 29th April 2016 at the
Bundeswehr Medical Academy in Munich:
Ernst von Bergmann Barracks
Neuherbergstrasse 11
80937 Munich
Germany
The conference will be held on military premises (Ernst von Bergmann Barracks). Access to the
barracks is possible only through the main gate and upon presentation of a valid passport or
military ID card. Please make sure that the number entered in the registration form exactly corresponds to the number shown on your passport/ID. If your name is not on the list kept by the
guard personnel, you may encounter problems entering the premises.
Conference Office / Registration Desk
The conference office is located next to the Audimax lecture hall, Entry B, Room 13.
Opening hours:
26 April 2016
27 April 2016
28 April 2016
29 April 2016
14:00 — 19:00
08:00 — 18:30
08:00 — 18:30
08:00 — 12:00
Following registration at the conference office, you are requested to wear your name tag inside the
barracks at all times.
Conference Fee
The mandatory conference fee of 110€ is an overhead fee covering all extras such as lunch buffet,
beverages served during coffee breaks, abstract book, congress bag, etc.
Participation in the Conference Dinner with Bavarian music and hospitality at the Eventstadel,
Moosach (Social Events) is optional. The Conference Dinner must be booked separately and will be
charged at 45€.
CME Points
The Conference is accredited by the Bavarian Medical Association. To earn CME credits, participants
are asked to register daily in the lists of the Bavarian Medical Association displayed at the registration
office. Please indicate your central CME reference number.
58
Registration and Support
Deutsche Gesellschaft für Wehrmedizin und Wehrpharmazie GmbH
Phone: +49 (0)228 63 24 20
For further details on registration options, please see the conference website
http://www.biodefense2016.org
Please note that there is no on-site registration option.
Industrial Exhibition
During the conference an industrial exhibition will be held by the German Society for Military Medicine
and Pharmacy (GSMMP/DGWMP) in the foyer of the Audimax lecture hall. For inquiries:
General Secretary of GSMMP/DGWMP
Neckarstraße 2a, 53175 Bonn
Phone: +49 (0)228 63 24 20
Fax:
+49 (0)228 698 53 3
Exhibitors and Sponsors
Sponsors:
Exhibitors:
Emergent Biosolutions
Abaxis
Accelerate Diagnostics S. L.
Berner International Corp.
AID Autoimmun Diagnostika GmbH
altona Diagnostics GmbH
analyticon instruments GmbH
Bruker Daltonik GmbH
CTL Europe GmbH
Euroimmun AG
GlaxoSmithKline GmbH & Co. KG
GS GLOVEBOX Systemtechnik GmbH
Hermes Arzneimittel GmbH
miprolab Mikrobiologische Diagnostik GmbH
New England BioLabs GmbH
Oxford Nanopore Technologies Ltd
Pfizer Pharma GmbH
Schülke & Mayr GmbH
STERIS Deutschland GmbH
ThermoFisher Scientific BRAHMS GmbH
59
General Information
Abstract Numbers
Abstract numbers are composed of a first letter (A-P), indicating the session to which the presentation has been assigned, a second letter, where O indicates an oral presentation and P indicates a
poster presentation, and a serial number. Abstracts are sorted according to their serial numbers in
the abstract book.
Advice for Speakers
Please prepare your presentation as a PowerPoint for Windows® file.
Check the Corrigenda and the "Program Changes Board" to find out if there are any changes to the
program that might relate to your presentation.
Make sure to bring your presentation to the media room at least 30 minutes before your session
starts. Files for early morning presentations should ideally be handed in the day before.
If possible, arrive at your presentation room prior to the start of the session and introduce yourself to
the chair.
Keep strictly to the scheduled presentation time, which includes the time for discussion. The chairpersons are advised to start the sessions in time and to terminate the lectures on schedule to avoid
any overrun.
Advice for Poster Presentations
Posters should be prepared in English. The format should not exceed DIN A0 (84.1 cm width x 118.9
cm height; portrait format), and the posters should not be laminated. Mounting materials will be provided. Your poster should be presented on the assigned poster board during the whole conference.
Additionally, there will be a special poster session (Thursday, 28th April 2016, 13:30-15:30) during
which one of the authors should be personally present at the poster. Poster presenters are encouraged to distribute one-page handouts.
Poster Awards
The German Society for Military Medicine and Pharmacy will honor three posters with a poster award
(kindly supported by altona Diagnostics GmbH), which will be presented to the award winners during
the poster award ceremony on 28th April 2016 at 16:00h.
1st prize: 500 EUR
2nd prize: 300 EUR
3rd prize: 200 EUR
Conference Language
The official conference language is English.
60
Meals and beverages
Lunch snack buffet (Wednesday and Thursday only) and beverages served during coffee breaks
(coffee, tea, soft drinks) are covered by the conference fee.
Meals are also available for purchase at the Officers Mess (payment in cash only). Casual dress is
acceptable for all meals. No shorts or sandals as per dress policy.
Participants may also use the Dining Hall (Bldg. 8) as well (payment in cash or with prepaid card
issued by Verpflegungsmanagement der Bundeswehr).
Opening hours Officers´ Mess:
Breakfast
Lunch
Dinner
07:00 - 11:00
11:00 - 13:00
16:00 - 22:00
Opening hours Dining Hall (Bldg. 8):
Breakfast
Lunch
Dinner
05:45 - 07:30
11:00 - 12:30
16:00 - 17:30
Social Events
Icebreaker
The German Society for Military Medicine and Pharmacy invites the participants
to a Welcoming Reception, which will take place on Tuesday, 26h April 2016,
18:00-21:30 in the Sergeants´ Mess on the premises of the Bundeswehr Medical
Academy. Participation is free.
Conference Dinner
The German Society for Military Medicine and Pharmacy invites the conference
attendees to a social event at the Eventstadel, Moosach / Wasserburg
(Wednesday, 27th April 2016, 19:00 - 22:30). Bus transportation to this location
will be available. Participation in the Conference Dinner will be 45 EUR for a
three-course menu (two beverages included). If you have not yet enrolled for the
Dinner in advance, please ask for residual tickets on-site at the registration desk.
Phone numbers
Conference office (during opening hours):
+49 (0)89 992692 4513
Officer on duty (room key pickup after closing of the conference office): +49 (0)89 992692 4600
Bundeswehr Institute of Microbiology:
+49 (0)89 992692 3981
In case of emergency call:
Medical center of the Academy: +49 (0)89 992692 3333 or Civilian Ambulance: 112
61
General Information
Travel and Transportation
Free shuttle bus service:
There will be a free shuttle service between „Harthof“ underground station (U2) and the conference
venue for your arrival on 26th April from 14:00 to 18:30 hrs and for late arrivals on 27th April from
8:00 to 9:00 hrs as well as for your departure on 28th April from 16:00 hrs to 19:00 hrs and on 29th
April from 07:00 hrs to 14:00 hrs.
The venue (Ernst von Bergmann Barracks) can be reached as follows :
By airplane:
The nearest airport is Franz-Joseph-Strauss Airport in Munich (MUC). To reach the center of Munich
you can use the Lufthansa Airport Shuttle Bus (operating from 06:25 to 22:25 hrs every 20 min; approx. 11 EUR for a single ticket) or the suburban train (S-Bahn S8, approx. 12 EUR for a single ticket) to the main station. You will also find car rental agencies or taxis at the airport (one-way taxi
fare approx. 50 EUR).
To directly reach the conference venue, use suburban train S1 and change to underground train U2
at Feldmoching. Get off at the stop „Harthof“. From there you can take the free shuttle bus or city bus
line 170 to „Kieferngarten“ or 141 to „Scheidplatz“ and get off at the stop „Rose-Pichler-Weg“, which
is right next to the main gate.
Further information: http://www.munich-airport.de/en/consumer/index.jsp
By train:
From the main station, take underground train U2 to Feldmoching and get off at the stop „Harthof“.
There, take the free shuttle bus or the city bus lines 141 or 170 to „Münchner Freiheit“ or
„Kieferngarten“. Get off at the stop „Rose-Pichler-Weg“ and you will find yourself right next to the
main gate.
Further information: http://www.bahn.de/i/view/USA/en/index.shtml
Use Google Route Planner to help guide you to the conference venue:
https://maps.google.com/maps?output=classic&daddr=%4048.21061124615,11.581563949585
By car:
Highway A8 Stuttgart-Munich:
At Eschenried intersection change to highway A99 to Salzburg. Take the exit Neuherberg, then drive
in the direction of Munich. After passing the city boundaries, turn right into Neuherbergstrasse at the
first traffic lights; after 400 m you will find the main gate on the left hand side
Highway A9 Nuremberg-Munich:
At Neufahrn intersection change to highway A92 to Stuttgart, then at Feldmoching junction to
highway A99 to Salzburg. Take the exit Neuherberg, then drive in the direction of Munich. After passing the city boundaries, turn right into Neuherbergstrasse at the first traffic lights; after 400 m you
will find the main gate on the left hand side.
62
Highway A8 Salzburg-Munich:
At the intersection München Brunnthal change to highway A99 to Nuremberg/Stuttgart, then stay on
the A99. Take the exit Neuherberg, then drive in the direction of Munich. After passing the city
boundaries, turn right into Neuherbergstrasse at the first traffic lights; after 400 m you will find the
main gate on the left hand side.
When arriving by car, please note that there are parking restrictions on the barracks’ premises.
Please do not park on reserved parking spaces.
Hotel shuttle bus
(provided by the German Society for Military Medicine and Pharmacy)
Guests staying at the recommended conference hotels may use the complimentary hotel shuttle bus on 27 to 29 April for commuting to the conference venue in the morning and back in the evening. You will be informed about departure times of the buses when checking in at the conference office. Guests
staying at other hotels should use public transport.
63
Map of Ernst von Bergmann Barracks
64
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
65
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________

Final Program ready for

Transcription

Similar documents

slide set

the saudi rising power

Lista expertilor care au participat la procesul de evaluare

ALUMNI 2012 DRUK.indd - Poznan University of Medical Science

TOPICS Magazin Numero 1/2014

Front Matter

Immunotherapy meets Lung Cancer: New treatments for

innsbruck austria - Unfallchirurgie Innsbruck

localization and broadband follow-up of the gravitational

In the beginning was the art! And with art came trash. The museums

Extraction of Stationary Components in Biosignal